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ABSTRACT OF DISSERTATION

NEW DEVELOPMENTS IN CYCLIZED ARSENIC AND ANTIMONY THIOLATES

There is a continued interest in the properties of arsenic thiolate compounds for
both industrial and biological uses. Recent discoveries in the medicinal properties of such
compounds have resulted in a sustained need for the synthesis of new dithiarsolane
compounds for research as anti-leukemic compounds. Close analogues of the 2-halo
arsenic dithiolates, namely those with an arsenic-carbon bond instead of an arsenic-halide
bond, have recently been shown to have some efficacy towards leukemia cells. Based on
the hydrolytic character and the active role of glutathione with arsenic in vivo, the
compounds reported here may also have such activity. Arsenic compounds have
demonstrated biological activity in the literature, thus the hypothesis of this thesis is
cyclized arsenic thiolates can be synthesized with the appropriate characteristics as to be
potentially useful medicinal agents as well as provide new structural and reaction
information. A series of arsenic and antimony di- and trithiolates has been synthesized
and characterized. Those compounds include 2-chloro-1,3,2-dithiarsolane, 2-bromo1,3,2-dithiarsolane, 2-iodo-1,3,2-dithiarsolane, 2-chloro-1,3,2-dithiarsenane, 2-bromo1,3,2-dithiarsenane, 2-iodo-1,3,2-dithiarsenane, 3-chloro-4H,7H-5,6-benz-1,3,2dithiarsepine, 2-chloro-benzo-1,3,2-dithiarsole, 1,2-bis-dithiarsolan-2-ylmercapto-ethane,
tris-(pentafluorophenylthio)-arsen, bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)benzenesulfide), 2-chloro-benzo-1,3,2-dithiastibole, and bis(2-(1,3,2-benzodithistibol)1,2-benzenedithiol.
Elucidation of the pH characteristics of arsenic dithiolates within the human
toxicity reaction pathway is an area of interest. It has been shown that the aqueous arsenic
dithiolate stability depends on the size of the ring. 2-Chloro-1,3,2-dithiarsolane has been
shown to be somewhat stable at both low and high pH as well as neutral pH. 1,2-bisDithiarsolan-2-ylmercapto-ethane is completely stable in a neutral aqueous solution.
Glutathione does not permanently bind to arsenic even in overwhelming excess.
In particular, these fully characterized compounds determine how reactive the
As–S and As–Cl linkages are under environmental and biological conditions, and provide
a source of new reagents to examine in medical applications. Future applications may

include the incorporation of the reported compounds in filtration and remediation
technologies with further modification.
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Chapter 1

Introduction

1.1

Overview
Arsenic dithiolates first became of interest as a product of the combination

between arsenic trichloride and 1,2-dithioethane. This reaction was completed as an
analogous reaction to the poisonous war gas Lewisite (ClCH=CHAsCl2) reacting with a
vicinal dithiol “cure”. It was the first purposeful and published synthesis establishing a
route for detoxification of nerve agents like Lewisite. The use of compounds such as 2,3dithiopropanol and 2,3-dimercaptosuccinic acid as cures for arsenic poisoning dates back
to the early 1900’s. Studies on the extensive medicinal properties of arsenic compounds
beyond Paul Ehrlich’s Salvarsan were not seen as important until recently with the
resurgence of As2O3 as a therapeutic compound. More recently, analogues of the 2-halo
arsenic dithiolates, namely those with an arsenic-carbon bond instead of an arsenic-halide
bond have recently been shown to have some efficacy towards leukemia cells. It is
speculated that the compounds reported here also have such activity. Based on the fact
that close analogues of the arsenic compounds reported here have biological activity, it is
the purpose of this research to synthesize cyclized arsenic thiolates with the appropriate
characteristics as to be potentially useful as medicinal agents as well as provide new
structural, characterization and reaction information.

1

The compounds reported herein are cyclized arsenic dithiolates with a terminal
halide, arsenic trithiolates, an antimony dithiolate with a terminal halide, and an antimony
trithiolate.
1.1.1

Cancer Treatment with As2O3 and Other Arsenic-containing Compounds
Arsenic has been used therapeutically for over 2400 years. Organo-arsenicals

have been studied in terms of their pharmaceutical uses for the last hundred-plus years
dating back to the early nineteen hundreds. There are pharmaceutical applications based
on Ehrlich’s use of Salvarsan in the treatment of syphilis. Arsenic trioxide (As2O3) was
used empirically to treat a variety of disorders, and in 1878, it was reported to reduce
white blood cell counts in two normal individuals and one with “leucocythemia.” Arsenic
trioxide is also known as an anti-bacterial and anti-cancer agent.[1] In the 1930s, arsenic
trioxide was reported to be effective in chronic myelogenous leukemia.
The medicinal use of arsenic-containing compounds declined during the mid-20th
century until it was reported from China that patients with acute promyelocytic leukemia
(APL) who had been treated with arsenic trioxide had a high proportion of hematologic
responses. The FDA approved the use of arsenic trioxide for relapsed or refractory APL
in September 2000.[2, 3] However, there is some disagreement in the literature on whether
or not arsenic induces apoptosis through down-regulation of B cell lines.[4, 5] There is also
a growing interest in the use of arsenicals for other diseases, such as the use of As2O3 in
treating malignant lymphoma.[6] It has been published that As2O3 exerts an effect on
lymphoid neoplasms.[7] Also, the use of arsenical derivatives such as melarsoprol may be
effective in the treatment of multiple myeloma.[8] In 2003, organic phenyl arsonic acid
derivatives were synthesized and shown to have antiluekemic activity in vitro.[9] In a
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recent publication, it was shown that compounds of the type shown in figure 1.1 have
anti-leukemic activity in vitro.[10] The in vivo application of such systems has not been
tested in humans. However, a U.S patent has already been issued for arsenic dithiolates
and other arsenic compounds as anti-cancer drugs.[11]

3

OH

S

S
As
R1

R2
R3

Figure 1.1. A structural representation of an arsenic dithiolate with anti-leukemic
activity.[10] The most promising variant has R1 as H, R2 as NHCOCH3 and R3 as OH.

4

1.2

Fundamental Properties of Arsenic
Heavier group 15 elements have been of interest since the beginning of recorded

history. The history of arsenic is broad and colorful. Ranging from early uses as poisons
and pigments to today’s applications in semiconductors, pesticides and main group
chemistry, arsenic has found its place in many areas of chemistry. Within the series of
arsenic, antimony and bismuth, arsenic has been the most studied. Arsenic is a grayish
white metalloid. Arsenic has an atomic number of 33, an atomic mass of 74.92159 g/mol
and only one stable isotope, 75As. Nitrogen, phosphorus, antimony and bismuth share
their outer electron configurations with arsenic. Usually, arsenic is grouped together with
the latter two elements due to similarities in chemistry, reactivity, size and similarities in
coordination chemistry.
1.3

Chemical and Physical Properties of Arsenic
Arsenic has a number of allotropes. α-Arsenic is crystalline and stable in dry air,

but in moist air the surface tarnishes until a grayish-black coating of amorphous β-arsenic
forms. Yellow arsenic or γ-arsenic is made up of As4 molecules similar to white
phosphorous. When elemental arsenic is heated in air, it sublimes and oxidizes to As4O6.
Arsenic combines with metals to give arsenides and with fluorine to produce AsF5. Other
halogens form compounds with the formula AsX3. Arsenic does not react easily with
non-oxidizing acids, alkaline solutions or water. Dilute nitric acid combined with arsenic
produces arsenous acid (H3AsO3), concentrated nitric acid yields arsenic acid (H3AsO4)
and concentrated H2SO4 yields As4O6. Combination of elemental arsenic with NaOH
produces hydrogen gas and sodium arsenite (Na3AsO3). One of the more marked
differences between nitrogen, phosphorus and arsenic is the difficulty to oxidize arsenic
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to the +5 oxidation state.[12] This is due to the underlying 3d orbitals, which more poorly
shield the 4s2 electrons from the element’s increased nuclear charge thus making them
harder to remove. Arsenic prefers, but is not limited to, three- and four-coordinate
species.
1.4

Geochemistry
The abundance of arsenic in crustal rock is 1.8 ppm, which places it fifty-first in

abundance compared to the other elements. Arsenic cannot be found in nature as a free
element. It is a chalcophile, which means that it often occurs in association with sulfur,
selenium and tellurium rather than as the oxide or silicate. However, the oxides are
formed from the weathering of the igneous ores. Some common arsenic-containing
minerals include arsenopyrite (FeAsS), realgar (As4S4), orpiment (As2S3), arsenolite
(As4O6) and lollingite (FeAs2). Oxo-arsenic species and their chemistry in natural waters
is an entire field of environmental speciation and remediation research. The aqueous
speciation of arsenic in water is dependent on several factors, such as the presence of
other dissolved species, Eh and pH. In water, arsenic exists as the neutral or anionic
species HxAsO3x-3 under anoxic conditions and HxAsO4x-3 under oxic conditions. At
neutral pH, the H3AsO3, H2AsO4-, and HAsO42- species predominate.[13-15]
1.5
1.5.1

Sources of Arsenic in the Environment
Natural
There are more than 200 mineral species containing arsenic, the most common of

which is arsenopyrite (FeAsS). Orpiment (As2S3), and realgar (As4S4) are the two
primary arsenic minerals due to their availability and high arsenic content. Volcanoes are
the most important natural source of arsenic in the environment in terms of the volume of
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released arsenic. However, weathering of arsenic-containing minerals is significant and
much more ubiquitous. West Bengal is a currently important example of an area affected
by arsenic mineral weathering. The source of arsenic in that area has been ascribed to the
reduction of arsenic-containing ferrous-coated sand grains and the oxidation of
arsenopyrite in the aquifer.[16, 17]
1.5.2

Anthropogenic
Elemental arsenic is produced commercially by the reduction of arsenic trioxide

(As2O3) with charcoal. As2O3 is produced as a by-product of metal smelting operations.
Mining, smelting of non-ferrous metals, and burning of fossil fuels are the major
industrial processes that contribute to anthropogenic arsenic contamination of air, water
and soil.
Historically, the use of arsenic-containing pesticides has left large tracts of
agricultural land contaminated. The use of CCA (copper chromium arsenate) as a wood
preservative is another source of contamination in the environment. Poultry operations
use roxarsone (1) to control coccidial intestinal parasites to improve feed efficiency. The
structure of roxarsone is shown in figure 1.2. Very little of the arsenic introduced in the
feed is retained by the animal. Most of the arsenic is excreted in urine and feces. It has
been estimated that this source produces 106 kilogram of arsenic per year.[18] Almost all
of the poultry litter is used as an agricultural fertilizer. The roxarsone-containing fertilizer
is spread over a field or tilled in. This is a common practice especially in grazing fields
and hay fields. The use of arsenic contaminated poultry litter as a fertilizer is a significant
source for arsenic contamination in agricultural surface waters.
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1.6

Current EPA Policy and Methods for Drinking Water Treatment
The U.S. Environmental Protection Agency (EPA) has accepted new limits on the

content of arsenic in drinking water. The new maximum contaminant level is 0.010 mg/L
which has gone into effect in 2006. Precipitation and co-precipitation are the most
frequently used methods for treating arsenic-contaminated water. This usually involves
adjustment of the pH to approximately 3 and addition of a chemical precipitant and
oxidant to convert the arsenite (As(III)) to arsenate (As(V)). Arsenate is considerably less
soluble than arsenite. The co-precipitants are usually ammonium sulfate, sulfide, ferric
chloride and ferric sulfate.[19] Membrane filtration, adsorption treatment and ion exchange
are also used. The membrane filtration techniques include micro-, ultra-, and nanofiltration. Reverse osmosis is also used. In adsorption techniques, a fixed bed of
adsorbent (most commonly activated alumina) adsorbs arsenic species in the water to its
surface. Ion exchange relies on passing the water through a strong base anion exchange
resin. As(III) is generally not removed by this method.[20]
1.7
1.7.1

Historical Notes on Arsenic
Cadet and Bunsen
One of the first organometallic compounds synthesized is generally considered to

be cacodyl (tetramethyldiarsine). It was the first example of metal-metal bonding and
played a vital role in the development of organometallic chemistry. French pharmacist,
Louis-Claude de Gassicourt (1731-1799) who was also known as Cadet de Gassicourt
was the first to prepare this organoarsenic compound, although he did not realize he had
done so. In his experiment, arsenic oxide was combined with potassium acetate and
heated in a furnace yielding what he called a “liqueur fumante”.[21] Through the use of
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Cadet’s fuming liquid, a large amount of research was performed by his contemporaries
which increased the understanding of organo-arsenic compounds and in turn laid the
groundwork for organometallic chemistry. The structures of tetramethyldiarsine (2) and
cacodyl cyanide (3) are given in figure 1.2.
R. W. Bunsen also investigated Cadet’s fuming liquid in the early to mid eighteen
hundreds. Unlike Cadet, Bunsen had a pension for doing chemistry on the kilogram scale
and so it was with the cacodyl compounds. Interestingly, Bunsen lived to the old age of
88. This is impressive considering a rash of accidents in his lab with potentially toxic
compounds such as cacodyl cyanide ((CH3)2AsCN).
1.7.2

BAL, British Anti-Lewisite
British Anti-Lewisite (BAL) was used in World War II as a treatment for poison

gas exposure. BAL refers to 2,3-dimercaptopropanol (4). The poisons were based on
organoarsenicals. Lewisite (5) is the best known poison from that era, although adamsite
(dibenzo-1-chloro-1,4-arsenine) was also used. Lewisite’s chemical name is (2chloroethenyl)arsonous dichloride. The structure of Lewisite, the structure of BAL and
the structure of the proposed product (6) are given in figure 1.3.
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Unfortunately, BAL has several undesirable side effects; it causes hypertension
and tachycardia as well as headache, nausea, vomiting, salivation, and pain. It is
generally given by intramuscular injection. The most common oral chelate in use today is
meso-2,3-dimercaptosuccinic acid (7) as seen in figure 1.2.
1.8

Industrial Uses
Elemental arsenic is obtained on an industrial scale by smelting arsenopyrite

(FeAsS) and loellingite (FeAs2) in an anoxic atmosphere between 650-700 °C.[12] Arsenic
is used industrially as an additive to glass to reduce coloring, in semiconductors, in
pigments such as Scheele’s Green (CuHAsO3), and in pesticides. Arsenic has been used
to treat lumber as copper chromium arsenate (CCA) but CCA was phased out of use at
the end of 2003. The addition of small quantities of As improve the properties of Pb/Sb
storage batteries also automotive body solder consists of Pb (92%), Sb (5.0%), Sn (2.5%)
and As (0.5%).
1.8.1

Laser Windows and Hall Devices
The III-V semiconductors, especially GaAs and InAs, are very important in the

fabrication of LEDs, tunnel diodes, infrared emitters, laser windows and Hall-effect
devices. AsH3 is also used as a dopant in semiconductors.
1.8.2

Pesticides
Arsenic-containing herbicides are readily available in most local hardware stores.

Disodium methylarsonate (DSMA), monosodium methylarsonate (MSMA), monomethyl
arsonic acid (MMA(V)) and arsenic acid are a few of the most common pesticides
available. These compounds are commonly used to kill crabgrass and other unwanted
grass types. There is only one commonly available arsenic-containing insecticide.
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Arsenic trioxide (As2O3) is commonly used as an ant insecticide. Arsenic pentoxide
(As2O5) is also used as an insecticide but is not very common. Arsenous acid and arsenic
acid are common rodenticides.
1.8.3

CCA Wood Treatment
CCA (copper chromium arsenate) wood treatment consists of pressure treating

wood which is usually to be placed in the ground. The arsenate leachate migrates shortly
thereafter into the surrounding soil. CCA use has been discontinued in the U.S. as of
2003. However, there are still wood products in the environment which were coated with
CCA which pose a continued point source for arsenic leachate.
1.9

Biological Chemistry of Arsenic
Arsenic and antimony can interact with proteins as nonmetallic oxyanions or as

soft metals through the formation of covalent bonds with the thiol groups on cysteines.[22,
23]

However, the actual molecular mechanism of inorganic arsenic toxicity is still not

known.
1.9.1

Oxidation-Reduction
Arsenic has complex and varied oxidation-reduction chemistry. The two most

common arsenic oxidation states are the +3 and + 5 state both in the environment and in
vivo. Arsenic (0) and arsenic (-3) exist but are not environmentally relevant as
contaminants. Arsenate and arsenite are the most common forms of arsenic found in the
environment and are the primary inorganic contaminants in water. Therefore the means
of methylation and the variations in toxicity of the two oxidation states compose an area
of significant interest and research.
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The metabolism of inorganic arsenic involves alternating steps of reduction from
As(V) to As(III) and oxidative methylation of the As(III) species.[24-26] This scheme is
known as the Challenger mechanism and can be seen in scheme 1.1. It has been shown
that the oxidative damage induced by arsenic in the body occurs through dimethylated
arsenic peroxide and not hydrogen peroxide or through a superoxide anion. Dimethylated
arsenic species may play a role in arsenic carcinogesis by causing oxidative damage.[27]
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1.9.2

Methylation
The methylation of arsenic seems to be the method higher biological systems use

to remove inorganic arsenic from the body. However, there is recent data suggesting that
the methylation produces more toxic species such as monomethylarsonous acid
(MMA(III)) and dimethylarsinous acid (DMA(III)).[28]
Only two enzymes have been extensively studied in the arsenic methylation
pathway, namely monomethylarsonic acid (MMA(V)) reductase and arsenic
methyltransferase which leaves gaps in the mechanism of how the oxidative methylations
and concurrent reductions occur. For example, it is still unknown which enzyme
catalyzes the methylation of arsenic in the human body.[29]
It has not been elucidated whether or not the formation of MMA(III) and
DMA(III) in the liver of higher vertebrates is part of the detoxification of arsenic in the
body, or if it is an intermediate product in a larger scheme. The commonly held pathway
for the methylation of arsenate to DMA(III) has been called into question. Hayakawa et
al. has proposed a pathway which places the MMA(V) and dimethylarsinic acid
(DMA(V)) as the end products and not as intermediates in the reaction pathway.[30]
Placement of DMA(V) and MMA(V) at the end of the detoxification route is an
advantage due to the fact that these species are the primary species found in urine
samples. It should be noted that the authors acknowledge issues with this proposed
pathway as well. For example, human CYT 19, the protein suggested to do the
methylation of the arsenic triglutathione by the Hayakawa et al. has only been
synthesized using recombinant DNA technology. It has not been isolated and purified
from human tissues.
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Biomethylation seems to require the complexation of arsenic with thiol groups.
This is probably due to the ability of the more electropositive sulfur over oxygen to make
the lone pair on arsenic more basic, thus making the lone pair more reactive to the
incoming methyl group. Also, it is easier to reduce arsenic (V) when bound to sulfur.[31]
1.9.3

Dealkylation
The biological methylation of arsenic has been studied extensively but the

demethylation of arsenic has not received similar attention.[32] Frederick Challenger
proposed the most widely accepted mechanism for arsenic methylation in 1945 and found
that 2-chloro-ethanearsonic acid (ClCH2CH2As(O)(OH)2) is converted to trimethylarsine
(As(CH3)3) by penicillium notatum. It was postulated that the arsenic-carbon between the
ethylene carbon and arsenic is broken followed by methylation to form trimethylarsine. It
has been reported that rats fed on arsenobetaine (Me3As+CH2COO-) excrete in urine,
among other products, the dealkylated products trimethylarsine oxide (TMAO),
dimethylarsenic acid (DMA(V)), monomethylarsenic acid (MMA(V)).[33] It has also been
reported recently that mycobacterium neoaurum demethylates methylated arsenicals.[32]
Several soil and sediment microorganisms can demethylate a wide range of
organoarsenicals. The mechanism by which microorganisms demethylate methylated
arsenicals is not known.[32]
1.9.4

Arsenic Resistance
There are arsenic resistant bacterium and microorganisms but the biological

mechanism for the resistance in unknown.[34, 35] There are several known arsenic operons
in single-celled organisms. Their regulatory abilities for arsenic (III) and (V) are based on
the formation of arsenic-cysteine bonds.[36] In fact, it is becoming clear that almost all
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bacteria and archaea have arsenic resistant (ars) operons which confer some resistance to
arsenate (V) and arsenite (III).[37] However, most resistance systems function by energydependent efflux of the respective ion.[38] Bacteria and fungi are known to produce
volatile and toxic arsines but the physiological roles of arsenic methylation in
microorganisms are unclear, and the biochemical basis is unknown.[39]
1.10 Human Arsenic Toxicology
Both organic and inorganic arsenic have an acute and long-term toxicity in
humans. However the organic arsenic compounds are not considered to have a systemic
toxicity.[40] As stated earlier, the mechanism(s) of the toxic action of inorganic arsenic are
unknown.[41-43]
Meat, fish, and poultry account for 80% of dietary arsenic intake. Organic arsenic
compounds such as arsenobetaine (Me3As+CH2COO-), arsenocholine
((CH3)3As+CH2CH2O-), tetramethylarsonium salts, arsenosugars and arsenic-containing
lipids are mainly found in marine organisms. They are sometimes referred to as “fish
arsenic”. Fish arsenic has a low toxicity in humans and is rapidly excreted in urine
without much metabolic modification. That is not to say that there is no toxic effect.
Arsenic (III) arsenosugars in particular will nick DNA plasmids. However, their toxicity
is considerably lower than that of dimethylarsinous acid.[44] Organic arsenical species
seem to be unaffected by human and higher vertebrate metabolism and as such are
excreted largely unchanged which indicates that organic arsenicals are not a significant
source of inorganic arsenic in vivo. This is especially true for trimethylarsenic with a
mouse LC50 >20,000 ppm inhalation.[45] There has been some interest as to whether the
inorganic arsenic species are linked with birth defects especially neural tube defects.
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However, it has been shown that in environmentally relevant scenarios, inorganic arsenic
is unlikely to produce birth defects.[46]
Recent research suggests that oxidative stress is the main cause of inorganic
arsenic-induced cell death, where organoarsenical toxicity is thought to be in response to
binding through thiol groups and inhibition of the activity of several enzymes.[47] Also,
arsenite has been shown to disrupt kinase activity by binding to cysteines which are
important to the activation of certain kinases.[48] It has also been shown that human
lymphoblastoid cells have a high affinity for As(III) species.[42] A study by Rey et al. has
proposed a molecular structure of As(III) bound by glutathione (GSH) (8).[49] The
proposed structure is shown in figure 1.4.
The speciation of arsenic in body fluids and a hint towards the longevity of
arsenic in the body has been reported. After two years of ceased exposure to arseniccontaining drinking water, detectable levels of arsenic were still found in human blood
serum.[50]
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Arsenite has been shown to inhibit pyruvate dehydrogenase activity by binding
with vicinal thiols in pure porcine heart enzyme and human leukemia tissue extract.
However, it is suggested that arsenite may be exerting its toxicity by promoting H2O2
production in the mitochondria and thus inactivating enzymes by protein oxidation.[43]
Arsenous acid and its trivalent methylated metabolites have been shown to react with
metallothionein.[51]
It has also been demonstrated that arsenite is able to distort polypeptide structure
in order to achieve a trigonal pyramidal environment in solution. This, in turn, indicates
that As(III) is able to distort biopolymers structurally. The structural affects of As(III) in
vitro may play a significant role in the toxicity of the material.[52]
Organoarsenicals can inhibit the pyruvate dehydrogenase system by reversibly
binding to vicinal dithiols on dihydrolipoamide.[53] It has been established that
organoarsenicals exert their toxicity by a different biological pathway than inorganic
arsenic and as such, chelating therapy for acute organoarsenic intoxication is not
necessary or helpful.[54] It has been recently shown that methylated trivalent arsenic
species are genotoxic.[55, 56] It has also been determined that the comparable pentavalent
arsenicals do not induce nicking or degradation of DNA. The trivalent arsenicals are
considered to be direct acting. This means they do not require enzymes or other outside
entities to exert their toxicity on DNA.
Human fetal brain development can also be affected by arsenic exposure. In a
recent study of human fetal brain explants, which were exposed to arsenic at 0.3 mg/L
concentration, the brain tissue experienced degradation due to reactive oxygen species. It
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was also found that the deleterious effects could be stemmed by addition of antioxidants.[57]
Arsenic analogues of phospholipids have been synthesized (arsinolipids) with
some success but an extensive study of their biological activity has not been
conducted.[58, 59]
1.11 ADP-Arsenate
A proposed but unsubstantiated mechanism for arsenic toxicity states that arsenate
can irreversibly bind to adenosine-5-diphosphate (ADP) in place of the third phosphate in
adenosine-5-triphosphate (ATP) and thus disrupt energy production in the cell. It has
been seen that arsenate in high concentrations can substitute for phosphate in enzyme
catalyzed reactions but it is postulated that the toxicity is not primarily due to the
substitution.[60] The structure of ADP-arsenate (9) is shown in figure 1.5.
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Arsenolysis is the inhibition of the in vitro formation of adenosine-5-triphosphate
by arsenate. ATP is the main high-energy species in vitro. On the substrate level, ATP
forms during glycolysis in the presence of phosphate. Arsenate however cannot form
ATP from the addition of ADP to arsenate. Adenosine-5-diphosphate–arsenate is also
synthesized in the mitochondria from adenosine-5-diphosphate ADP and arsenate in the
presence of succinate. ADP-arsenate formation at the substrate and mitochondrial level
reduce ATP formation and thus inhibit many enzymatic reactions. More information on
this particular system can be found in Hughes, 2002 and references therein.[61]
1.12 Conclusion
As can be seen from the previous sections, arsenic has a history as a component in
toxic war agents, a cure for syphilis, a cancer treatment, a water contaminant and so on.
The biological activity of arsenic in the body covers a broad spectrum from toxic to
therapeutic agent. Based on the fact that arsenic compounds such as
phenylarsenicdithiolates shown in figure 1.1 and similar organo-arsenic dithiolates are
reported to have exhibited biological activity towards cancerous cells, it is suggested that
cyclized arsenic thiolates can be synthesized with the appropriate characteristics as to be
potentially useful as medicinal agents. This study also provides new structural and
reaction information for the arsenic thiolate species in novel compounds which increases
our understanding of the arsenic thiolate moiety. The targeted compounds would be those
having an arsenic atom bound by two thiolate groups in a cyclic system, but with a
potentially reactive halide group, still retain their biological activity. This hypothesis was
to an extent confirmed in a recent patent where compounds such as S-dimethylarsinothiosuccinic acid, S-dimethylarsino-salicylic acid, and S-(dimethylarsino) glutathione
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were patented for use as anti-leukemic drugs.[11] What is required is to demonstrate that
these compounds can be prepared and that the dithiolate unit would remain intact under
aqueous conditions. For medical purposes the compounds would be used by direct
contact with the tumor.
There is also a continued interest in the properties of arsenic and antimony
containing thiolate compounds for both industrial and other biological uses as discussed
in previous sections. The compounds reported herein will attempt to bring some light to
these and other questions. In particular, these fully characterized compounds provide an
understanding of the sulfur-arsenic interaction in living systems, determine how reactive
the As–S and As–Cl linkages are under environmental and biological conditions, and
provide a source of new reagents to examine in medical applications. There is also
application for the reported compounds in filtration and remediation technology with
some further modification.

Copyright © Taimur Shaikh 2007
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Chapter 2

Heterocyclic Halo-Arsenic Dithiolates and Trithiolates

2.1

Overview
In this chapter the synthesis and full characterization of five-, six- and seven-

membered arsenic thiolate compounds is presented. These compounds provide new
structural data. The compounds are also examples of target compounds for biological
testing on leukemic cells. The work was successful as several halo-arsenic dithiolates and
arsenic trithiolates were synthesized and characterized. The primary reagents chosen for
synthesis of the arsenic thiolates were arsenic trichloride, arsenic tribromide, arsenic
trifluoride, and the respective thiols. Also, the arsenic trithiolates have been shown to be
stable in aqueous solution. The aqueous stability of such compounds implies that the
compounds if biologically active have the stability needed to be useful as medicinal
agents.
A pH study was conducted to test if the arsenic thiolate heterocycles were stable
towards hydrolysis. It was demonstrated that the five-membered halo arsenic dithiolates
are to some extent stable in pH 2 and 11 solutions and it was shown that the larger sevenmembered cycles are not as stable in solutions at the respective pH’s. This indicates that
the 2-halo-arsenic dithiolate heterocycles are as such not suitable as a remediation
technology.
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2.2

Background
There has been an interest in the 2-halo-1,3,2-dithiarsolanes and their derivatives

since the use of Lewisite (Cl2AsCH=CHCl) 5 and similar toxic arsenic-containing
warfare agents in World War II. Lewisite would be vaporized over the battle field and
inhaled functioning similarly to common blistering agents like mustard gas. The first
paper on the disposal of Lewisite was published in 1946 and described the synthesis of
the non-toxic solid, 2-chloro-1,3,2-dithiarsolane, from arsenic trichloride and 1,2-ethane
dithiol.[62] The motivation for the synthesis of such compounds was the need for a way to
safely dispose of Lewisite and other arsenic chlorides in the late 1940s and 1950s. 2Chloro-1,3,2-dithiarsolane was synthesized according to the reaction shown in scheme
2.1. The synthetic route involves the formation of two equivalents of hydrogen chloride
gas, which can be used to monitor the progress of the reaction which goes to completion
at room temperature. A comprehensive study on various synthetic routes available using
1,2-bis-dithiarsolan-2-ylmercapto-ethane as a starting material appeared in 1967. The
aforementioned compound was synthesized by the addition of 6 equivalents of ethane
dithiol to one equivalent of arsenic trioxide (As4O6).[63, 64] Since that time, very little work
in this area has been done. However, the synthesis of arsenic dithiolate cations as carbene
analogues, an example of which is seen in figure 2.1 was successful in the late eighties
and early nineties.[65-67] The arsenic dithiolate cations can be synthesized by halide
abstraction with aluminum trichloride or gallium trichloride, thus forming the appropriate
anion.
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AsCl3 (l) + HS(CH2)2SH (l)

AsBr3 (s) + HS(CH2)2SH (l)

Acetone

AsCl3 (l) + HS(CH2)3SH (l)

AsBr(S(CH2)3S) (s) + 2 HBr (g)

CCl4

AsCl(S(CH2)3S) (s) + NaI (s)

Acetone

AsCl3 (l) + HSCH2(C6H4)CH2SH (l)

CCl4

3 AsCl(S(CH2)2S) (s) + 3 H2O (l)

3 C6F5SH (l)

2 AsF3 (l) + 4 HSC6H4SH (l)

AsI(S(CH2)2S) (s) + NaCl (s)

AsCl(S(CH2)3S) (s) + 2 HCl (g)

CCl4

AsBr3 (s) + HS(CH2)3SH (l)

AsF3 (l) +

AsBr(S(CH2)2S) (s) + 2 HBr (g)

CCl4

AsCl(S(CH2)2S) (s) + NaI (s)

AsCl3 (l) + HSC6H4SH (s)

AsCl(S(CH2)2S) (s) + 2 HCl (g)

CCl4

AsI(S(CH2)3S) (s) + NaCl (s)

AsCl(SCH2(C6H4)CH2S) (s)

CCl4

AsCl(SC6H4S) (s)

+ 2 HCl (g)

+ 2 HCl (g)

Na2CO3 (aq)
THF/H2O

CCl4

CCl4

(SCH2CH2S)As(SCH2CH2S)As(SCH2CH2S) (s)
+ As(OH3) (aq) + HCl (aq)
As(SC6F5)3 (s) + 3 HF (g)

(C6H4S2)As(SC6H4S)(SC6H4S)As(S2C6H4) (s)
+ 3 HF (g) + H2 (g)

Scheme 2.1. Examples of synthetic routes to various di- and tri-thioarsenic compounds.
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Figure 2.1. A bis(1,3-dithia-2-arsolidinium) cation (10).
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The 2-halo-1,3,2-dithiarsenic compounds as well as the arsenic trithiolates were
synthesized according to the synthetic pathways shown in scheme 2.1. The synthetic
routes involved the formation of the respective equivalents of hydrogen chloride, or
hydrogen bromide or the formation of an insoluble salt as the driving force behind the
reactions. The reactions can be monitored by observing gas evolution or salt formation
and go to completion at room temperature.
One of the first single-crystal X-ray structure determinations of an arsenic
dithiolate was conducted in 1972 by Cruse and James.[68] A molecular structure of the
product of arsenite and 1,4-dithiothreitol is shown in figure 2.2. 8-Oxa-2,7-dithia-1-arsabicyclo(1,3,2)-octan-4-ol (11) was the first structurally characterized example of an
arsenic dithiolate ring.
Complexes of British Anti-Lewisite and phenyldichloroarsenic and a complex of
dimercaptosuccinic acid and phenyldichloroarsenic have been synthesized. They were
formed by addition of the respective dithiol to phenyldichloroarsenic in acetone. The
BAL adducts seem to be more stable in comparison to the dimercaptosuccinic acid
derivatives due to exchange seen in the NMR spectra with trace water.[69]
With the previous work conducted as a stepping stone and an interest in the
medicinal efficacy of arsenic dithiolates, the author set out to synthesize, characterize and
understand the aspects of the arsenic dithiolate and trithiolate moiety. A list of the
compounds synthesized for this chapter are given in figure 2.3.
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Figure 2.2. The molecular structure of 8-oxa-2,7-dithia-1-arsa-bicyclo(1,3,2)-octan-4-ol
(11).
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Figure 2.3. A structural representation of the arsenic dithiolates (12-22).
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2.3
2.3.1

Experimental Section
General

Caution. Arsenic compounds are toxic and should be handled with care.
AsCl3 was purchased from Alfa Aesar. AsF3 was purchased from SynQuest Labs. Both
AsCl3 and AsF3 are highly toxic and carcinogenic and must be handled and disposed
of as hazardous materials. The dithiols obtained from Aldrich were used as delivered
without further purification. All manipulations were carried out using standard
inert atmosphere techniques under a nitrogen atmosphere.
NMR spectra were obtained at room temperature in CDCl3 on Varian Gemini 200
or Varian Innova 400 NMR spectrometers. Chemical shifts are reported in ppm, relative
to tetramethylsilane. 19F spectra are referenced to α,α,α-trifluorotoluene. FT-IR spectra
were recorded as KBr pellets on a Varian Spec 9800. GC-MS data were obtained on
either an Agilent Technologies 6890N GC system with an Agilent Technologies 7683B
injector and an Agilent Technologies 5973N mass selective detector or on a Varian
CP3800 GC with a Varian Saturn 2200 Ion Trap MS and CTC Analytics CombiPAL
autosampler. Melting points were obtained on a Mel-Temp melting point apparatus.
X-ray diffraction data were collected at 90 K on a Nonius Kappa CCD diffractometer unit
using Mo Kα radiation from colorless regular shaped crystals mounted in Paratone-N oil
on glass fibers. Initial cell parameters were obtained using DENZO from 1° frames and
were refined by a least-square scheme using all data-collection frames
(SCALEPACK).[70] The structures were solved by direct methods (SHELXL-97) and
completed by difference Fourier methods (SHELXL-97).[71] Refinement was performed
against F2 by weighted full-matrix least-square. Hydrogen atoms were placed at
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calculated positions using suitable riding models with isotropic displacement parameters
derived from their carrier atoms. Non-hydrogen atoms were refined with anisotropic
displacement parameters. Atomic scattering factors were taken from the International
Tables for Crystallography volume C.[72] Details of crystal data, data collection, and
structure refinement are listed in the appendix.
2-Chloro-1,3,2-dithiarsolane (12)
1,2-Dithioethane (2.39 g, 25.4 mmol) in 50 mL CCl4 was added drop-wise to arsenic
trichloride (5.03 g, 28.0 mmol) in 50 mL CCl4 at room temperature. The reaction was
stirred for an hour and then moved to a freezer at -20 oC where 5.13 g of a crystalline
solid formed overnight. The crystals were kept at -20 oC and the solution filtered off to
obtain a yield of 97.9%. Mp: 38.5–39.0 oC. 1H NMR (CDCl3): δ 3.77 (m, 4H). 13C NMR
(CDCl3): δ 44.63 (s). IR (ν, cm-1, KBr): 3448 (m, br), 2951 (m), 2910 (m), 1722 (w),
1642 (w), 1409 (s), 1384 (m), 1281 (m), 1231 (w), 1144 (w), 1106 (w), 992 (w), 930 (m),
832 (s), 669 (w), 644 (w), 599 (w), 450 (w). Mass spectra (GC–MS): 202
(AsCl(SCH2CH2S))+, 167 (As(SCH2CH2S))+.
2-Bromo-1,3,2-dithiarsolane (13)
1,2-Dithioethane (0.59 g, 6.28 mmol) in 30 mL CCl4 was added drop-wise to arsenic
tribromide (2.22 g, 7.06 mmol) in 30 mL CCl4 at room temperature. Gas evolved upon
addition. The reaction was stirred for twelve hours under N2 with intermittently venting
to the atmosphere and then moved to a freezer at -20 oC where 0.42 g of a crystalline
solid formed overnight. The crystals were kept at -20 oC and the solution filtered off to
obtain a yield of 27.1%. The crystals were not of sufficient quality and so were
recrystallized in CDCl3/CHCl3 to obtain high quality crystals. Mp: 48-49 oC. 1H NMR
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(CDCl3, ppm): δ 5.00 (-CH2-, s, 4H). 13C NMR (CDCl3, ppm): δ 45.22 (-CH2-). IR (ν,
cm-1, KBr): 2965.95 (m), 2915.42 (m), 1629.40 (w), 1409.73 (s), 1384.17 (w), 1280.86
(m), 1232.31 (m), 1145.53 (w), 1111.12 (w), 994.38 (m), 930.93 (s), 834.88 (s), 661.47
(m), 649.92 (s) 452.49 (m). Mass spectra (GC-MS): 248 (BrAs(SCH2CH2))+, 167
(As(SCH2CH2))+, 107 (AsS)+.
2-Iodo-1,3,2-dithiarsolane (14)
Sodium iodide (0.75 g, 5.00 mmol) was dissolved in 20 mL of acetone and added dropwise to 2-chloro-1,3,2-dithiarsolane (1.01 g, 5.00 mmol) dissolved in 20 mL acetone at
room temperature. A white precipitate formed and the solution turned red. The solvent
was removed under vacuum to isolate an orange solid. This solid was recrystallized from
CCl4/CHCl3 to yield 1.14 g of crystalline solid (78.0%). Mp: 74.0-74.5 oC. 1H NMR
(CDCl3): δ 3.81 (d, 4H). 13C NMR (CDCl3): δ 46.07 (s). IR (ν, cm-1, KBr): 3447 (m, br),
2960 (w), 2902 (w), 1628 (m), 1403 (m), 1277 (w), 1106 (w), 929 (w, sh), 827 (m), 664
(m), 445 (w). Mass spectra (GC-MS): 294 (AsI(SCH2CH2S))+, 167 (As(SCH2CH2S))+.
2-Chloro-1,3,2-dithiarsenane (15)
1,3-Dithiopropane (2.75 g, 25.5 mmol) was dissolved in 25 mL of CCl4 and added dropwise to a solution of arsenic trichloride (5.04 g, 27.1 mmol) in 25 mL CCl4 at room
temperature. The reaction was stirred for an hour and the solution cooled to -20 oC and
kept at that temperature for 24 h at which point a white crystalline precipitate formed.
The solution was filtered and the resulting solid dried completely, yielding 4.96 g of a
crystalline solid in 90.0% yield. Mp: 40.5-41.0 oC. 1H NMR (CDCl3): δ 3.50 (m, 2H), δ
3.06 (m, 2H), δ 2.27 (m, 2H). 13C NMR (CDCl3): δ 26.587 (s), δ 25.797 (s). IR (ν, cm-1,
KBr): 3448 (m, br), 2904 (m), 2820 (w), 2360 (w), 1635 (w), 1416 (s), 1338 (w), 1296
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(m), 1269 (m), 1245 (m), 1179 (w), 1115 (w), 995 (w), 899 (w), 855 (w), 803 (w), 739
(w), 618 (m), 411 (w). Mass spectra (GC-MS): 216 (AsCl(SCH2CH2CH2S))+, 181
(As(SCH2CH2CH2S))+.
2-Bromo-1,3,2-dithiarsenane (16)
1,3-Dithiopropane (0.71 g, 6.57 mmol) was dissolved in 30 mL of CCl4 and added dropwise to a solution of arsenic tribromide (2.27 g, 7.21 mmol) in 40 mL CCl4 at room
temperature. Upon addition, gas evolved from the solution. The reaction was stirred for
twelve hours under N2 with intermittently venting to the atmosphere. Approximately 15
mL of solvent was removed via evaporation. The solution was then cooled to -20 oC and
kept at that temperature for one week after which approximately 30 mL of solvent was
removed under vacuum and 5 mL of CH2Cl2 and 5 mL of acetone were added and the
solution was cooled to -20 oC at which point a white crystalline solid formed. The
solution was filtered and the resultant solid dried completely, yielding 1.53 g of a
crystalline solid in 89.0% yield. Mp: 30-31 oC. 1H NMR (CDCl3): δ 3.29 (-CH2-, m, 2H),
δ 3.19 (-CH2-, m, 2H), δ 2.24 (-CH2-, m, 2H). 13C NMR (CDCl3): δ 27.15 (-CH2-), δ
26.66 (-CH2-). IR (ν, cm-1, KBr): 2906.11 (s), 2817.47 (m), 1418.10 (s), 1337.91 (w),
1297.27 (m), 1271.23 (s), 1239.73 (m), 1179.42 (m), 1142.29 (w), 1115.79 (w), 996.77
(w), 899.26 (m), 855.92 (s) 804.64 (m), 738.11 (w), 674.76 (w), 621.01 (m), 491.69 (w),
454.06 (w). Mass spectra (GC-MS): 262/260 (BrAs(SCH2CH2CH2S))+, 181
(As(SCH2CH2CH2S))+, 107 (AsS)+.
2-Iodo-1,3,2-dithiarsenane (17)
Sodium iodide (0.75 g, 5.00 mmol) in 10 mL acetone was added to 2-chloro-1,3,2dithiarsenane (1.08 g, 4.99 mmol) dissolved in 20 mL of acetone at room temperature.
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Both solutions were clear before addition. Upon addition, the solution took on a bright
orange tint and a white precipitate formed. The white precipitate was filtered out and part
of the solvent was removed from the solution under vacuum. The solution was then
allowed to crystallize and 0.24 g of dark red orange crystals formed at -20 oC in a 15.6%
yield. Mp: 45-46 oC. 1H NMR (CDCl3, ppm): δ 3.24 (t, 4H), δ 2.29 (p, 2H). 13C NMR
(CDCl3, ppm): δ 31.14 (s), δ 26.95(s). IR (ν, cm-1, KBr): 3448 (m, br), 2896 (m), 2832
(m), 2364 (w), 1627 (m), 1412 (s), 1364 (w), 1293 (w), 1265 (m), 1179 (w), 892 (w), 851
(w), 802 (w), 775 (w), 616 (w). Mass spectra (GC-MS): 308 (AsI(SCH2CH2CH2S))+, 181
(As(SCH2CH2CH2S))+.
3-Chloro-4H,7H-5,6-benz-1,3,2-dithiarsepine (18)
1,2-Bis-mercaptomethylbenzene (1.00 g, 5.87 mmol) was dissolved in 20 mL of CCl4 and
added drop-wise to arsenic trichloride (1.20 g, 6.62 mmol) in 20 mL CCl4 at room
temperature. The reaction was stirred overnight and cooled to -20 oC and kept at that
temperature for a week. Clear star-like crystals formed in the solution. The solvent was
then removed yielding 1.57 g of a crystalline solid in a yield of 96.2%. Mp: 117-119 oC.
1

H NMR (CDCl3, ppm): δ 7.17 (phenyl, m, 4H), δ 5.11 (CH2, d, 2H), δ 3.934 (CH2, d,

2H). 13C NMR (CDCl3, ppm): δ 139.31, δ 130.51, δ 129.60 (-phenyl-), δ 33.20 (-CH2-).
IR (ν, cm-1, KBr): 3448 (wb), 3055 (w), 3026 (w), 2964 (w), 2933 (w), 1643 (w), 1493
(s), 1440 (s), 1416 (w), 1385 (w), 1301 (w), 1236 (m), 1211 (w), 1185 (m), 1156 (w),
1073 (w), 949 (w), 860 (w), 828 (w), 766 (vs), 762 (s), 666 (s), 589 (m), 499 (m).
Mass spectra (GC-MS): 243 (As(SCH2)2(C6H4))+, 168 ((SCH2)2(C6H4))+, 104
((CH2)2(C6H4))+.
2-Chloro-benzo-1,3,2-dithiarsole (19)
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1,2-Benzenedithiol (0.50 g, 3.5 mmol) in 20 mL CCl4 was added drop-wise to arsenic
trichloride (0.70 g, 3.9 mmol) in 20 mL CCl4 at room temperature. The reaction was
stirred for an hour and then moved to a freezer at -20 oC where crystals formed overnight.
The crystals were kept at -20 oC. The solution was filtered and 0.55 g of a crystalline
material was obtained with a yield of 62.9%. Mp: 87.5-88.0 oC. 1H NMR(CDCl3, ppm,
400 MHz): δ 7.59 (benzene, m, 2H), δ 7.23 (benzene, m, 2H). 13C NMR (CDCl3, ppm,
100 MHz): δ 139.49 (=CS-), δ 127.11 (=CH-), δ 126.37 (=CH-). IR(ν, cm-1, KBr): 3438
(wb), 3057 (m), 1900 (w), 1630 (m), 1556 (w), 1445 (s), 1422 (s),1384 (m),1274 (w),
1249 (w), 1135 (w), 1106 (m), 934 (m), 847 (w), 741 (s), 660 (m), 470 (m), 429 (m).
Mass spectra (GC-MS): 215 (As(SC6H4S)) +, 108 (SC6H4)+.
1,2-Bis-dithiarsolan-2-ylmercapto-ethane (20)
2-Chloro-1,3,2-dithiarsolane (1.01 g, 5.00 mmol) was dissolved in 20 mL of THF and an
aqueous solution of Na2CO3 (1.00 g, 9.43 mmol, in 60 mL H2O) was added to form a
white precipitate. The solution was stirred for 5 minutes and then filtered to isolate 0.379
g of a white precipitate in a yield of 53.4%. The precipitate was dissolved in a
50/50 solution of CHCl3/CH3OH and slowly evaporated to obtain X-ray quality crystals.
Mp: 81.5-82.0 oC. 1H NMR (CDCl3): δ 3.507 (m, 8H), δ 3.106 (s, 4H). 13C NMR
(CDCl3): δ 42.722 (s), δ 35.890 (s). IR (ν, cm-1, KBr): 3449 (b), 2947 (w), 2906 (s), 1594
(m), 1409 (s), 1275 (s), 1195 (s), 1110 (w), 991 (w), 929 (w), 831 (s), 720 (w), 679
(m), 645 (w), 451 (w). Mass spectra (GC-MS): 167 (AsSCH2CH2S)+.
tris-(Pentafluorophenylthio)-arsen (21)
Arsenic trifluoride (1.00 ml, 20.02 mmol) was dissolved in 5 mL of CCl4 and
pentafluorothiophenol (5.40 mL, 40.50 mmol) was dissolved in 20 mL of CCl4. Upon

37

slow addition of the two solutions, a white precipitate formed. The reaction was left
stirring for 24 h under a N2 atmosphere. The solvent was then removed and the
precipitate was dissolved in a mixture of CH2Cl2, toluene, acetonitrile and
trifluorotoluene in a 1:1:3:3 ratio. The solvent mixture was evaporated slowly to produce
9.068 g of X-ray quality crystals in a yield of 99.96%. Mp: 76-77 oC. 19F NMR (CDCl3,
ppm): δ -135.29 (m)(C-F meta), δ -153.35 (m)(C-F para), δ -164.27 (m)(C-F ortho). IR(ν,
cm-1, KBr): 1637 (m), 1488 (s), 1401 (w), 1377 (w), 1291 (w), 1093 (vs), 1019 (w), 980
(vs), 859 (vs), 723 (w), 634 (w), 417 (w). Mass spectra (GC-MS): 473 (As(SC6F5)2)+, 274
(As(SC6F5))+.
Bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-benzenesulfide) (22)
Arsenic trifluoride (1.02 g, 7.74 mmol) was added drop-wise to 1,2-benzenedithiol (1.00
g, 7.03 mmol) neat at room temperature. 10 mL of CCl4 and 10 mL of CH2Cl2 was added
and the reaction was stirred overnight and cooled to -20 oC and kept for a week. Yellow
block-like crystals formed in the solution. The solvent was then removed yielding 0.45g
of a crystalline solid with a yield of 36.0%. Mp: 158-160 oC. 1H NMR (CDCl3, ppm): δ
7.60 (phenyl, q, 2H), δ 7.47 (phenyl, q, 2H), δ 7.45 (phenyl, q, 4H), δ 7.22 (phenyl, q,
2H) δ 7.11 (phenyl, q, 2H), δ 7.08 (phenyl, q, 4H). 13C NMR (CDCl3, ppm): δ 143.75 (phenyl-), δ 139.99 (-phenyl-), δ 135.57 (-phenyl-), δ 128.92 (-phenyl-), δ 127.00 (phenyl-), δ 1125.81 (-phenyl-). IR (ν, cm-1, KBr): 3430.61 (vwb), 3048.05 (m), 1627.75
(mb), 1444.02 (s), 1436.66 (s), 1418.31 (w), 1384.42 (m), 1271.38 (w), 1246.87 (w),
1105.89 (m), 1032.19 (m), 800.57 (s), 737.29 (vs), 658.78 (w), 479.23 (w), 424.50 (w).
Mass spectra (GC-MS): 281 (SC6H4SSC6H4S)+, 248 (SC6H4SSC6H4)+, 215 (AsSC6H4S)+,
171 (AsS3)+, 139 (AsS2)+ ,108 (SC6H4)+, 107 (AsS)+.

38

2.4
2.4.1

Results
Spectroscopy
The 1H NMR spectrum of 12 shows a multiplet (3.77 ppm) for the ethylene

protons and the 13C NMR spectrum shows a singlet (44.63 ppm) for the ethylene carbons.
It can be concluded that there is only one magnetic environment for the ethylene carbons.
The IR spectrum for compound 12 is strikingly similar to compounds 13-19. The C–S
stretches at 669 and 644 cm-1 and As–S stretch at 450 cm-1 indicate the presence of a
ring.[73, 74]
The IR and Raman spectra of 13 have been reported previously by Gates et al.[74]
The characterizational data published previously for 13 matches well with the data
obtained. The 1H NMR spectra of 13 shows only one signal at 5.00 ppm which has been
assigned to the methylene protons. This indicates that there is only one magnetic
environment for the ethylene protons. The

13

C NMR also shows one signal which is at

45.22 ppm which has been assigned to the ethylene carbons. The IR spectrum shows the
characteristic C–S stretches at 661 cm-1 and 650 cm-1 and the As–S stretch at 452 cm-1.
The 1H NMR spectrum of 14 shows a doublet (3.81 ppm) for the ethylene protons
and the 13C NMR spectrum shows a singlet (46.07 ppm) for the ethylene carbons. Just as
in 12, it can be concluded that there is only one magnetic environment for the ethylene
carbons. Some of the spectroscopic data reported here does not match the published data
available for 14.[73, 75] In particular, the 1H NMR signal at 3.81 ppm differs considerably
from the published value of 3.00 ppm. This could be due to solvent effects (CDCl3 vsrsus
C6D6). Also, the IR spectrum shows the characteristic C–S and As–S stretches at 664 and
445 cm-1, respectively.
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In compound 15, there are three multiplets (3.50, 3.06 and 2.27 ppm) for the
hydrogens on the propylene carbons, which are similar to the previously reported values
of 3.43, 2.76, and 1.85 ppm. The differences can be attributed to the use of different
NMR solvents (CDCl3 versus C6D6).[76] The fact that there are three 1H NMR signals is
due to the axial and equatorial signals from the protons on C1 and C(1A) and a multiplet
due to the protons on C2. Pyramidal inversion is possible at the arsenic but with a high
energetic barrier (25-42 kcal/mol), the inversion is slow.[77, 78] This explains the three
distinct multiplets seen in the 1H NMR. The IR spectrum shows the C–S stretch (618 cm1

) and the As–S stretch (411 cm-1).
Apparently 16 is a new compound and has not been previously characterized by

structural or spectroscopic means. The 1H NMR data obtained for 16 shows three signals.
They have been assigned as 3.29 ppm and 3.19 ppm belonging to the two proton
environments seen on C1 and C3. The axial and equatorial protons experience different
environments. The protons on C2 at 2.24 ppm are split to a lesser degree due to a smaller
coupling constant which results in one multiplet for the protons on C2. The

13

C NMR

spectrum yields two signals at 27.15 ppm and 26.66 ppm respectively which coincide
with the two different carbon environments. The infrared spectrum shows the As–S bond
at 492 and 454 cm-1 and the C–S bonds are seen at 675 and 621 cm-1.
The 1H NMR of 17 shows a triplet and a pentet (3.24, 2.28 ppm) for the
hydrogens on the propylene backbone. The 13C NMR shows two singlets (31.14, 26.95
ppm) which correspond to the ortho and para positions, respectively. The IR spectrum
shows the C–S stretch (616 cm-1) but the As–S stretch is not observed. This is most likely
due to the band falling very close to the edge of the range of the instrument (400 cm-1).
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The spectroscopic data are consistent with what is expected based on the IR, 1H and 13C
NMR of the chloro analogue.
The spectroscopic data obtained for compound 18 relates well to the published
information available.[79] The 1H NMR show the phenyl hydrogens (7.17 ppm), and
methylene hydrogens (5.11, 3.93 ppm). The methylene hydrogens are in different
magnetic environments and are split. This is due to the anomeric effect which states that
the heteroatomic substituent prefers an axial alignment in the heterocycle. Two of the
hydrogens on the methyl groups are closer to the chlorine and are in different
environments. The 13C NMR shows the carbon in the phenyl ring (139.31, 130.51, 129.60
ppm) and the methyl carbons (33.20 ppm). The strong bands at 766 cm-1 and 661 cm-1 in
the IR spectrum indicate an anti-symmetric stretch and a symmetric stretch between
carbon and sulfur, respectively. This is unusual because these bands are usually weak and
the anti-symmetric band is rarely observed. The As–S stretch is shifted higher than seen
in the other compounds at 500 cm-1.
Compound 19 has two multiplets in the 1H NMR (7.59 and 7.23 ppm) which
correspond to the benzene protons. The 13C NMR spectrum yields three signals (139.49,
127.11, and 126.37 ppm) which correspond well with the benzene carbons. The IR
spectrum yields the characteristic peaks expected for an arsenic dithiolate. The C–S
stretch can be seen at 660 cm-1 and As–S stretches are seen at 470 and 429 cm-1. A
similar compound, 2-chloro-5-methyl-1,3,2-benzodithiarsole, was reported previously
and uses the toluene 3,4-dithiol moiety to bind to the arsenic center.[80] The reported
compound differs from compound 19 by having a methyl group in the 1-position in
reference to the 3,4-dithiol moiety.
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The 1H NMR spectrum of 20 shows a multiplet (3.51 ppm), which arises from the
ethylene hydrogens in the ring, and a singlet (3.11 ppm), which is due to the bridging
ethylene hydrogens. There are two signals in the 13C NMR spectrum, a singlet due to
ethylene carbons in the ring (42.72 ppm) and a singlet due to the bridging ethylene
carbons (35.89 ppm). The IR spectrum shows three bands which represent the A// ring C–
S stretch (679 cm-1), A/ ring C–S stretch (645 cm-1) and A/ As–S ring deformation (451
cm-1). These are similar to the published values.[1]
The 19F NMR of 21 shows the fluorines in the meta, para, and ortho positions on
the phenyl rings (-135.29, -153.35, -164.27 ppm), respectively. The IR spectrum obtained
indicates an aromatic C–C stretch (1489 cm-1), C–F stretches (1094 cm-1, 980 cm-1), a C–
S stretch (860, 635 cm-1), and an As–S stretch (417 cm-1).
Compound 22 has six signals corresponding to the phenyl protons in the 1H NMR
and six signals in the 13C NMR which is consistent within the molecule. Nine magnetic
environments exist for the carbon atoms however the carbons with no protons are not
seen due to a lack of the Nuclear Overhauser Effect (NOE). Compound 22 displays the
characteristic IR bands seen in organo-arsenic thiolates. The band at 659 cm-1 is
indicative of C–S bonds and the peaks at 479 and 425 cm-1 are in the correct range for
As–S bonds in the ring.[73, 74] However, the As–S stretches are usually weak.
2.4.2

Structure
Compound 12 has been crystallized in both the P21/c and P212121 space groups.

The X-ray structure of 12 has been previously reported.[66, 81] However, the crystals were
crystallized in the monoclinic space group P21/c, whereas 12 was also crystallized in the
orthorhombic space group P212121. This was achieved by changing the conditions of
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crystallization. Compound 12 was dissolved in CCl4 and a molar equivalent of benzyl
alcohol added and then recrystallized in the orthorhombic space group. The alcohol
clearly influenced the crystallization but does not appear in the structure. In the
orthorhombic P21/c space group the variance in bond lengths between As and S on the
same molecule is approximately 0.0314 Å whereas in the P212121 space group the As–S
bonds have a variance of approximately 0.0188 Å. These values lie within or are
extremely close the value of 0.02 Å, which is the limit for experimental error in the single
crystal X-ray structure determination.
Crystal dimorphism as seen in 12 is of great theoretical and practical interest.
Different morphs of the same material can have a range of physical, chemical and
biological properties.
Compound 13 has been extensively characterized by spectroscopic means as well
as by electron diffraction. However, a single crystal X-ray structure determination of this
molecule has not been reported until now. An electron diffraction study was conducted
on 13 by Zaripov et al.[82] Compound 13 crystallizes in the orthorhombic space group
P212121. The bond lengths and angles are very similar to the previously reported halo1,3,2-dithiarsolanes.[66, 81, 83] Thus, varying the terminal halide from Cl to Br to I, seems
to have little effect on the bond angles and distances within the five-membered
heterocyclic ring. Compound 13 exhibits strong intermolecular interaction between the
As1 and the S2 of its nearest neighbor. The arsenic atom in each molecule takes on
pseudo four-coordinate geometry with a sulfur atom within 0.2 Å of the sum of the van
der Waals radii.
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Compound 14 contains two molecules in its asymmetric unit and crystallizes in
the monoclinic space group Cc. The bond lengths and angles are very similar to 12 as
seen in Table 3. Thus, varying the terminal halide seems to have little effect on the bond
angles and distances in the halo-dithiarsolanes. However, the distance between I(1)B to
S(2)A is 3.745 Å in the packing diagram and as such is within the sum of the Van der
Waals radii for I and S at 3.78 Å. The slightly shortened distances are likely due to the
packing within the unit cell. However, the As(1A)–I(1A) distance is 2.65 Å which when
compared to the sum of the covalent radii (2.54 Å) is longer, indicating a more ionic
bond.
The halo-1,3,2-dithiarsolanes crystallize in different space groups. However,
varying the terminal halide from Cl to Br to I, seems to have little effect on the bond
angles and distances within the heterocycle indicating a very defined heterocyclic
structure which in unaltered by variation in the terminal group.
Compound 15 crystallizes in the orthorhombic space group Pnma. The S–As–S
bond angle is 102° which is considerably wider than in the five-membered rings.
However, this has little effect on the As–S bond length (2.22 Å). Thus, there are no
strong distortions in either the five- or six-membered ring compounds containing As–Cl
bonds. In the unit cell, the intermolecular arsenic hydrogen distances are around 3.02 Å,
while the chlorine hydrogen distances are around 2.90 Å. Both of these values are within
the sum of the van der Waals radii (3.05 and 2.95 Å) of the respective atoms.
Compound 16 crystallizes in the monoclinic space group P21/c. The structural
data obtained for 16, when compared to the structural data previously obtained for 2chloro- and 2-iodo analogues 15 and 17, shows almost identical bond lengths between all
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the atoms except the As–X (X=Cl, Br, I) naturally. The bond angle S–As–S has a
variance within a 1.6° between the 2-chloro-, 2-bromo- and 2-iodo-1,3,2-dithiarsenane
analogues. Therefore, it can be said that the identity of the halide has very little effect on
the six-membered heterocyclic ring.
Compound 17 crystallizes in the monoclinic space group P21/n. The iodine atom
seems to have little effect on the bond angles and bond distances of the molecule versus
the chlorine analogue of course with the exception of the As–I bond length and angles
including As–I. In the solid state, the iodine breaks the symmetry of the molecule
whereas the chlorine analogue maintains a higher level of symmetry with a σv (vertical
mirror plane) passing through the middle of the molecule and containing the halide. This
could be due to larger displacement of the iodine atom and a slight shift of the iodine
away from the symmetry axis. The As–S bonds are slightly elongated and the angle made
by S–As–X is widened by 2.4° more in the iodo complex but the S–As–S bond angle is
slightly smaller in the iodo complex, 102.20° versus 101.42° in the chloro analogue and
100.60° for the bromo analogue.
Compound 18 crystallizes in the orthorhombic space group Pnma. The chosen
route to obtain a seven membered arsenic dithiolate ring involves ‘‘locking’’ the
backbone forming a 1,3,2-dithiarsepine heterocycle. The S–As–S bond angle in 18
demonstrates considerable strain from the normal trigonal pyramidal geometry by having
the largest angle seen thus far at 105°. There are no π-stacking effects observed in the
structure of 18. The arsenic and backbone carbons are approximately 3.55 Å apart which
coupled with the molecular geometry around As causes the lone pair of the arsenic to be
centered directly over the phenyl ring.
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A structural representation of compound 19 is shown in figure 2.9. The structure
is similar to that of compound 12 in terms of bond lengths and bond angles around
arsenic. In the structure of the toluene analogue (ClAs(SC7H7S)) published by Wandiga
et al., the actual S–As–S ring structure also resembles what is found in 12.[80] This lends
credence to the values obtained here. The single crystal X-ray structure of compound 19
was not able to be completely refined due to the unit cell containing 17 distinct
molecules. This is not a realistic representation of the packing within the crystal.
However, the determined values for the bond lengths and bond angles are valid. The
values used for comparison of bond length are the average of all seventeen molecules.
Whereas, the values used for the bond angles were taken from molecule J in the
seventeen molecule asymmetric unit. The values were taken from one molecule however
all of the molecules in the structure had very small bond angle variations. If the
asymmetric unit is correct, it would make compound 19 crystallographically unique. The
unit cell contains the number of molecules needed to complete a repeating unit in three
dimensions. Within that unit cell, there can be a number of asymmetric units. Compound
19 would have an odd number of molecules in its asymmetric unit and have a high
number of molecules which is a rarity.
Compound 20 crystallizes in the orthorhombic space group P212121. The As–S
bond lengths range from 2.23-2.28 Å and the S–C bond lengths are around 1.81-1.84 Å.
These are typical As–S and S–C bond lengths. However, there is a narrowing of the bond
angle between S1–As1–S2 and S5–As2–S6 in compound 20 and the angle made with the
sulfur located on the linkage. The constriction is approximately 6° with a range from 93°
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to 102°. Consequently, the five-membered rings do not deviate significantly from a
distorted trigonal pyramidal structure at the arsenic center.
Compound 21 crystallizes in the orthorhombic space group Fdd2 and has As–S
bond distances of 2.26–2.27 Å which is in the expected range. However, the angles
around the arsenic center are somewhat unexpected. Two of the angles lie in the region of
98.3°– 98.5° whereas one is significantly more acute at 87.8°. It is possible that the bond
angle constriction is due to steric interactions between the pentafluorothiophenyl groups.
The bond lengths between the arsenic center and the different sulfurs vary from one
another by only 0.06 Å.
Compound 22 crystallizes in the C2/c space group. The arsenic sulfur distances
are almost identical between compounds 18 and 22. The sulfur-arsenic-sulfur bond angle
is considerably larger in 18 versus 22 at 105.06° vs. 91.86°, but this is due largely to the
sizes of the backbones. Structurally, the bond lengths seen in 22 are consistent with
previously reported compounds. The As–S bonds in 22 range from 2.23 Å to 2.29 Å.
Compound 22 demonstrates As–π interactions which are notable due to the unusually
close As(III)–aromatic carbon distances. However, this is now a well known
characteristic of As–aromatic systems. For example, in a self-assembled arsenic thiolate
macrocycle published by Darren Johnson, a close As–Caryl contact is found at 3.16 Å
which is well within the sum of the van der Waals radii.[84, 85] To better understand the
structure and bonding of 22, the compound is compared to 3-chloro-4H,7H-5,6-benz1,3,2-dithiarsepine (18). There is no π stacking interaction between the arenes in 18 in the
solid state, whereas the short distances between centroids of adjacent arenes of 22 in the
solid state suggest a strong intramolecular interaction.
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Compounds 20, 21, and 22 are very similar in their As–S bond lengths. In
comparison to organo-arsenic dithiolates there is very little difference in the bond length.
For example, as seen in the work of Kolis et al., the As–S bond lengths range from 2.23
to 2.28 Å in a toluene arsenic-BAL derivative, 2-p-tolyl-1,3,2-dithiarsolan-4-yl-methanol
(23).[69] A figure of the characterized compound 23 by Kolis et al. is shown in figure
2.15.
There are two ways an arsenic thiolate can be thought of as a ligand. The arsenic
atom itself can function as an electron donor through its lone pair of electrons in As(III)
containing thiolates. The other means of ligand function would be through a reactive thiol
on the arsenic center. It may be expected that the metal coordinated compounds have a
considerable difference in the As–S bond distances due to the more electropositive metal
bound to the arsenic. However, it has been shown by Khandelwal et al. that an arsenicmetal bond does not affect the As–S bond length. This can be seen in the compound
[Mo(η2-As(SCH2CH2S)(CO)2(η-C5H5)] (24). Even with a donor interaction of one of the
sulfurs to the Mo center, the As–S bond lengths range from 2.25 to 2.28 Å and the S–As–
S bond angle is approximately 93.3°.[86, 87]
The metal complexes of the 2-methyl-1,3,2-dithiarsolane (25) (four-coordinate
As(III)) have been reported but have not been structurally characterized.[88] The structures
of 24 and 25 can be found in figure 2.16.

48

Figure 2.4. Molecular structure of 2-chloro-1,3,2-dithiarsolane (12). Hydrogen atoms
have been omitted for clarity.
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Figure 2.5. Molecular structure of 2-bromo-1,3,2-dithiarsolane (13). Hydrogen atoms
have been omitted for clarity.

50

Figure 2.6. Molecular structure of 2-iodo-1,3,2-dithiarsolane (14). Hydrogen atoms have
been omitted for clarity.
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Figure 2.7. Molecular structure of 2-chloro-1,3,2-dithiarsenane (15). Hydrogen atoms
have been omitted for clarity.
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Figure 2.8. Molecular structure of 2-bromo-1,3,2-dithiarsenane (16). Hydrogen atoms
have been omitted for clarity.
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Figure 2.9. Molecular structure of 2-iodo-1,3,2-dithiarsenane (17). Hydrogen atoms have
been omitted for clarity.
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Figure 2.10. Molecular structure of 3-chloro-4H,7H-5,6-benz-1,3,2-dithiarsepine (18).
Hydrogen atoms have been omitted for clarity.
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Figure 2.11. Molecular structure of 2-chloro-benzo-1,3,2-dithiarsole (19). Hydrogen
atoms have been omitted for clarity.
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Figure 2.12. Molecular structure of 1,2-bis(dithiarsolan-2-ylmercapto)ethane (20).
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Figure 2.13. Molecular structure of tris(pentafluorophenylthio)arsen (21).

58

Figure 2.14. Molecular structure of bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)benzenesulfide) (22). Hydrogen atoms have been omitted for clarity.
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Figure 2.15. Structural diagram of 2-p-tolyl-1,3,2-dithiarsolan-4-yl-methanol (23).
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Figure 2.16. Structural diagrams of metal complexes 24 and 25.
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S

2.5

Aqueous Stability
In a recent publication, arsenic triglutathione (8) as seen in figure 1.4 was found

to form non-enzymatically from arsenite in solution with a concentration of 2 mM
glutathione or higher. L-glutathione is a tripeptide and its IUPAC name is 2-amino-5-{[2[(carboxymethyl)amino]-1-(mercaptomethyl)-2-oxoethyl]amino}-5-oxopentanoic acid. It
has been suggested that the arsenic triglutathione complexes are converted to the monoand dimethyl variants by arsenic methyltransferase. It was also found that at low
concentration (<1 mM) of glutathione, the arsenic glutathione species became unstable
and hydrolyzed to the methyl arsenate species in vitro.[30]
The non-enzymatic formation of arsenic triglutathione and its derivatives is important
because it elucidates viable arsenic species in the body. The arsenic thiolates seems to be
the preferred arsenic species in the body over arsenic oxo-species. In fact, it is suggested
that glutathione plays an important role in arsenic transport.[89] It has been previously
concluded that in response to arsenic, combined activation of the caspases and downregulation of Bcl-2 could determine the fate of B-cell leukemic cells.[5] Thus, it is of
importance to discover whether or not the reported compounds here are maintained in
solution and in the presence of glutathione.
Previous work on the aqueous chemistry of 2-halo-1,3,2dithiarsolanes has been
limited to brief descriptions of compounds formed inadvertently due to aqueous solvents.
The overall outcome of such reactions has been the formation of arsenic trithiolates from
the dithiolate and the conversion of one equivalent of the arsenic dithiolate into arsenous
acid (As(OH)3) or the formation of a disulfide. A manuscript published by Sommer et al.
in 1967 contains the earliest work on these types of compounds in aqueous solution and
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includes the synthesis of the hydrolytically stabile 20 and similar compounds reacting in
aqueous solution.[63] However, an in-depth study has not yet been conducted as to the
stability of these types of compounds in an aqueous environments, let alone at various
pHs. This aspect of the chemistry of the halo-arsenic dithiolates and arsenic trithiolates
dictates the stability of these types of compounds in the body which is of importance if
they are to have any chance at being effective in vivo.
As previously stated, there is very little in the published literature on the pH
stability of these compounds. A search of SciFinder Scholar on November 13, 2006,
yields no publications on the topic of the pH stability of the compounds of interest.
However, it is of note that compound 12 has been found to react with water to form 20,
HCl, and As4O6 as can be seen in scheme 2.2.[63] Scheme 2.3 shows a stepwise scheme to
20.
Thus, to further test the aqueous stability of these types of compounds, this study
has been done. The information gleaned from the study has importance in eventual
applications of these compounds for aqueous use. It is to be made known whether or not
these compounds should be stabile in water, and are they stabile in the presence of
glutathione.

62

6

S

S

S
As

Cl + 3 H2O

2

As

S

As

S

S

S

S

+ 0.5 As4O6 + 6 HCl

Scheme 2.2. The scheme for the hydrolysis of 12 first published by Sommer et al.[63]
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Scheme 2.3. A two-step scheme for the hydrolysis of 12.
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2.5.1

Method Employed
In an attempt to elucidate the aqueous chemistry of the 2-halo-1,3,2-dithiarsenic

heterocycles, compounds 12 and 18 were subjected to a pH study at pH 2 and 11 as well
as a pH neutral solution. The compounds were added to buffer solutions of pH 2 and pH
11 at room temperature, stirred, and left in the respective buffer solutions for 24 hours.
After extracting the solutions with CH2Cl2, the organic solutions were characterized by
GC-MS. The aqueous solutions were evaporated and the recovered solid was analyzed
through IR and melting point. Crystals of the product of compound 12 in a buffer of pH
11 were recovered but were unable to be solved through single crystal X-ray structure
analysis.
Compound 20 was added to a pH neutral solution to elucidate whether the arsenic
trithiolate-containing compounds would be susceptible to hydrolysis at neutral pH. The
crystals remained in the solution for two weeks, and then the solution was extracted with
dichloromethane and analyzed by GC-MS.
In addition, the effects of glutathione in solution were investigated. Compound 12
was added to an aqueous solution with a stoichiometric amount of l-glutathione at room
temperature. The solution was stirred for 4 days and then extracted with CH2Cl2. THF
was added to the aqueous layer in an attempt to crystallize the remaining material by
slow evaporation. The organic layer was pumped down. Acetone and THF were added to
the solution and it was placed at -20°C for one week.
2.5.2

Results
Arsenic trithiolate species do not react in aqueous solution at any appreciable

level over a two week period in pH neutral water. This has been demonstrated by
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compound 20 not reacting in aqueous solutions and by the recrystallization of the same
compound from an organic extraction with an almost quantitative yield of 90%.
Halo arsenic dithiolates are not stable in aqueous solution. However, due to the
hydrolysis being slow in pH 2 buffer solution, compound 12 can be extracted into CH2Cl2
and is characterized by GC-MS. Table 2.1 contains the mass fragments found and
correlates them to known species. Compound 18 was used to verify the pH stability and
to see if the hydrolysis was as slow as seen in 12. However, compound 18 did not yield
the same compound upon extraction. In fact, the organic fractions of compound 18, both
at pH 2 and pH 11, yield the identical mass spectrum. They both yield the dithiolate
ligand without the arsenic in almost quantitative yield as seen by the GC-MS spectrum.
Therefore, it is concluded that the seven-membered ring compound is not stable in
aqueous solution.
The pH 11 product of 12 yielded a mixture of approximately 50% starting
material and 50% compound 20. This result supports our findings as well as the findings
by Sommer et al. that the primary product of the hydrolysis of compound 12 is compound
20. However, it is of interest to note that approximately one half the starting material was
still present even after twenty-four hours. Thus it can be stated that the hydrolysis
reaction is relatively slow at room temperature with the concentrations used.
Moreover, the product of the l-glutathione reaction with compound 12 also
yielded crystalline compound 20 in 77.4% yield. The aqueous layer yielded a nearquantitative amount of a white solid which was characterized by IR, 1H and 13C NMR as
l-glutathione with a yield of 93.8%.
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Thus it can be concluded that the compounds in question do not hydrolyze
completely over the short term (24 hours with substantial degradation) and the interaction
of l-glutathione does not inhibit hydrolysis of the chloride to the arsenous acid and
compound 20. The aqueous availability of the active arsenic species is essential to having
any chance of biological efficacy. As can be seen from the reported work here, the
arsenic center can react in aqueous solution.
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Table 2.1. Mass fragments found in aqueous study.

Compound 12

Compound 18

Compound 20

pH 2 - CH2Cl2

pH 7 - CH2Cl2

202 (AsCl(SCH2CH2S))+

202 (AsCl(SCH2CH2S))+

167 As(SCH2CH2S))+

167 As(SCH2CH2S))+

167 As(SCH2CH2S))+

139 AsS2+

139 AsS2+

139 AsS2+

107 AsS+

107 AsS+

107 AsS+

168 (SCH2)2C6H4+

168 (SCH2)2C6H4+

168 (SCH2)2C6H4+

104 (CH2)2C6H4+

104 (CH2)2C6H4+

104 (CH2)2C6H4+

167 (AsSCH2CH2S)+

Mass spectra obtained in positive ion mode. Ions created by EI.
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pH 11 - CH2Cl2

2.6

Conclusion
The ease with which the six-membered rings break upon addition of base and the

inability to form and isolate the seven-membered ring compound implies that the fivemembered ring is the least reactive in the series of n = 2, 3, and 4 in the alkylene linkage
in AsX(S(CH2)nS) where X is the halide. Conversely, there is no evidence to show that
the dithiarsepane (As(S(CH2)4S)) ring, if formed, is stable. The possibility of
rearrangement into an oligomeric form seems more likely due to the mass spectral data
obtained from failed attempts at the synthesis of the 2-chloro-dithiarsepane. After several
attempts, 2-chloro-1,3,2-dithiarsepane was not isolated and characterized. When arsenic
trichloride and 1,4-dithiobutane are combined at room temperature a white emulsion
forms which when extracted into CS2, gives much higher molecular weight species than
would be expected for 2-chloro-1,3,2-dithiarsepane.
Results from the successful syntheses reported in the present work indicate that
the As–S bonds in cyclized five-membered halo arsenic dithiolates are both somewhat
acid and base stable but undergo immediate salt eliminations and redistribution with
larger cycles in both acidic and basic conditions. Certain combinations of chelate length
are more susceptible to breakage of the chelate As–S bonds in the salt elimination
process. This is most obvious in the synthesis of arsenic trithiolates from their dithiolate
derivatives. The truncated As–S bonds shown in these compounds (bond lengths within
the sum of the covalent radii) and the slightly elongated bond lengths of the arsenic
halides indicate the unequal orbital hybridization as called for by Bent’s rule.
Unfortunately, the variances in bond lengths are inconclusive due to experimental error.
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Compounds 12–19 display an axial alignment of the halide on the arsenic center
with respect to the ring. As can be seen from the structural data, bond distances and
angles are not affected by the identity of the terminal halide. This explains the
spectroscopic similarity between 12, 13, 14 and 19 and between 15, 16 and 17.
Compound 20 seems to be the preferred product in reactions involving ring
hydrolysis of five-membered rings. This is due to the ease of hydrolysis of the terminal
halide analogues and the stability of the trithioarsenic moiety to hydrolysis. This stability
was also seen in the pharmacological attributes of non-alkylating dithiarsenicals which
were tested for efficacy against cancers as early as 1966.[1] It is interesting to note that
compounds which were found then to be ineffective against cancers have recently been
shown to have just such an efficacy.[10]
In compound 12, it was previously postulated that the 2-chloro-1,3,2-dithiarsolane
is first hydrolyzed at the As–Cl bond followed by breakage of the As–S bond by water,
which then provides a free sulfhydryl group which can react with another equivalent of
12 to eliminate HCl.[62] However water does not seem to be the only solvent that will
function successfully to break the As–S bond since in the present case this occurs in CCl4
with the addition of excess NaHCO3, which means a wide range of solvents both polar
and non-polar should be conducive to the As–Cl bond breakage.
There has been some interest in compound 17 in radioarsenic labeling where an
72

As atom would be used as a positron emitter as it decays to 72Ge.[90] It has been

suggested that compound 17 could be used to label biomolecules with 72As. This would
be the first “no carrier added” arsenic labeling and could find use in positron emission
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tomography. However, it is not noted whether the compound is stable to hydrolysis at
biologically relevant pH and Eh or whether it needs to be to deliver the nuclide.
Compound 21 was synthesized to determine the bond length of the As–S bonds in
the absence of a ring structure yet retaining the electron-withdrawing power of a pseudohalide. It was thought that the addition of strongly electron withdrawing groups would
shorten the As–S bond. Pentafluorothiophenol, which was used in the synthesis of
compound 21, has been used to make various metal complexes including arsenic
complexes.[91, 92] However, only the elemental analysis data and the melting point were
reported previously. This work sought general information in the basic chemistry of As–S
bonding and specifically whether the presence of fluorine would lead to stronger
bonding. In theory, arsenic trithiolates mimic the bonding between arsenic and three
glutathione molecules. Nonetheless, 21 exhibits very similar As–S bonds to those in 20.
The lack of any real variation in the As-S bond length in 21 indicates that the
pentafluorothiophenyl group bound to the arsenic yields similar arsenic-sulfur bonds as
those found in the cyclized arsenic dithiolates. The inductive effect which is defined by
the International Union of Pure and Applied Chemistry (IUPAC) as the transmission of
charge through a chain of atoms in a molecule by electrostatic induction does not seem to
be noticeable through the sulfur atom. Sulfur, which is considered in hard-soft acid-base
theory to be a soft base, does not transmit charge due to said softness.
Compound 22 demonstrates intramolecular π-stacking in the solid state. The
crystal structure reveals channels of alternating benzene rings. As a coordinating ligand
through the arsenic lone pairs, or as a basis for metallocenes in molecular self assembly,
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this molecule could have interesting utility as a ligand. Also, compound 22 is the first
reported arsenic trithiolate compound with an intramolecular organic disulfide linkage.
The fully characterized compounds reported here provide compounds for
comparison with arsenic glutathione metabolites and of what are up to this point other
speculated arsenic thiolate metabolites in living systems. It has been determined that the
As–S linkages and the As–Cl bonds are reactive in aqueous conditions. Based on what
has been demonstrated, the bonding interactions of glutathione to arsenic in the
heterocyclic compounds is not strong enough to overcome the formation of an arsenic
trithiolate in the presence of 1,2-dithioethane. This suggests that the overall toxicity seen
for arsenic thiolates in leukemia cells in due primarily to the arsenic moiety.

Copyright © Taimur Shaikh 2007
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Chapter 3

Antimony Dithiolates and Trithiolates

3.1

Overview
Antimony and arsenic thiolate chemistry share several similarities. Due to the

similarities between arsenic and antimony in size, electronegativity, reactivity and
reaction preferences, they both exhibit very comparable chemistry. Like arsenic, the most
common oxidation states of antimony are (III) and (V). Nonetheless, examples of Sb(0)
and Sb (-III) are known as well, for example, elemental antimony and SbH3 respectively.
Antimony thiolate chemistry, while not possessing the wide range of biological activity
of arsenic has interesting features. For example, antimony dithiolates tend to adopt higher
coordination numbers than arsenic which are of structural interest. In addition, it is
postulated that antimony trioxide forms antimony triglutathione in vivo which is
analogous to arsenic. The molecular coordination geometries usually seen for antimony
are distorted trigonal pyramidal, tetrahedral and octahedral. The higher range of possible
coordination numbers for antimony is often reached by secondary interactions. The
synthesized antimony compounds are to be compared against their arsenic analogues but
also seen as their own separate entity.
3.1.1

Fundamental Properties of Antimony
Antimony is a grayish white metalloid. It has the atomic number of 51, an atomic

mass of 121.760 g/mol and two stable isotopes, 121Sb and 123Sb. Antimony shares its
outer electron configuration with nitrogen, phosphorus, arsenic and bismuth. Usually, it is
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grouped together with the latter two elements due to similarities in chemistry, reactivity,
size and similarities in coordination chemistry.
3.1.2

Chemical and Physical Properties of Antimony
Antimony has a number of allotropes. α-Antimony is crystalline and isostructural

with α-arsenic and α-bismuth. In addition to α-antimony, there are five more forms of
elemental antimony. β-Antimony is what is normally referred to as rhombohedral
antimony or just antimony and is a silver-white solid with a high metallic luster.
3.1.3

Geochemistry of Antimony
The most important antimony-containing ore is stibnite, Sb2S3.The abundance of

antimony in crustal rock is 0.2 ppm, which places it sixty-second in abundance compared
to the other elements. Antimony can occasionally be found in nature as a free element.
There are several other minerals containing antimony including ullmanite (NiSbS),
livingstonite (HgSb4S8), tetrahedrite (Cu3SbS3), and wolfsbergite (CuSbS2). Small
amounts of the oxides are formed by weathering and include valentinite (Sb2O3),
cervanite (Sb2O4), and stibiconite (Sb2O4.H2O).
3.1.4

Biological Activity of Antimony
Antimony is not as biologically active as arsenic. Sb2O3 has an acute oral toxicity

which is much higher than the achievable dosing limit of 28 g/kg and has been found not
to be genotoxic in vivo.
In fact, Sb (V) compounds are used as the drug of choice in treating particular
ailments such as human leishmaniases. Leishmaniases are a group of diseases which are
caused by the invasion of a human host by the parasite belonging to the genus leishmania.
There are approximately two million new cases every year. There are two forms;
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cutaneous and visceral leishmaniasis. The cutaneous form is usually manifested as sores
on the skin. The visceral form is manifest by fever, weight loss, and an enlarged spleen
and liver.
The standard procedure is treatment with antimony (V) compounds such as
meglumine antimonate or sodium stibogluconate.[93] It should be noted that the structure
of meglumine antimonite is poorly understood although it has been in use for over fifty
years.[94] It has been suggested that glutathione (GSH) reduces the previously mentioned
meglumine antimoniate drug to Sb(GS)3.[93] The formation of Sb(GS)3 has also been
shown to occur with potassium antimony (III) tartrate.[95] Cysteine, cysteinyl-glycine and
tripanothione have also been shown to reduce Sb (V) containing complexes to their Sb
(III) derivatives.[96]
3.1.4.1 Biomethylation of Antimony
The monomethylated and dimethylated antimony species have been seen as
intermediates in the methylation pathway to trimethylstilbine. There is some evidence
which suggests that antimony proceeds via the Challenger mechanism which can be seen
in scheme 1.1, and is the accepted arsenic biomethylation pathway in the body.[97]
3.2

Antimony Thiolates
In the literature, antimony-sulfur covalent bond lengths fall in the range of 2.40-

2.50 Å for single bonds and result in compounds with a trigonal pyramidal molecular
geometry. Very little is known about antimony (III) dithiolates. In fact, a search of
heterocyclic compounds containing the S–Sb–S moiety with Sb in the (III) and (V)
oxidation states yields 204 journal references in Scifinder Scholar. Most of these
compounds are coordination compounds with CN of 4-6. However, there are several
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antimony thiolate compounds which are similar in structure to compounds 12-22 reported
here as well. For example, the IR and Raman spectra of the simple antimony analogues of
12, 13 have been reported.[74]
The compounds synthesized here are to be compared against other known
antimony dithiolates and trithiolates such as a compound reported by Wandiga et al. in
which an antimony (V) derivative bound to three benzenedithiol ligands has been
structurally characterized.[80]
When the Sb–S and Sb–Cl bond lengths in the compounds are also to be
compared to an eight-membered ring compound published by Vela et al., who obtained a
crystal structure of the antimony dithiolate.[98]
3.3
3.3.1

Experimental Section
General
SbCl3 and SbF3 were purchased from Aldrich and used as received. The dithiols

were obtained from Aldrich and were used as delivered without further purification. All
manipulations were carried out using standard inert atmosphere techniques under a
nitrogen atmosphere. NMR spectra were obtained at room temperature in CDCl3 on
Varian Gemini 200 or Varian Innova 400 NMR spectrometers. Chemical shifts are
reported in ppm, relative to tetramethylsilane. FT-IR spectra were recorded as KBr pellets
on a Varian Spec 9800. Melting points were obtained on a Mel-Temp melting point
apparatus.
X-ray diffraction data were collected at 90 K on a Nonius Kappa CCD
diffractometer unit using Mo Kα radiation from colorless, regular-shaped crystals
mounted in Paratone-N oil on glass fibers. Initial cell parameters were obtained using
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DENZO from 1° frames and were refined by a least-square scheme using all datacollection frames (SCALEPACK).[70] The structures were solved by direct methods
(SHELXL-97) and completed by difference Fourier methods (SHELXL-97).[71]
Refinement was performed against F2 by weighted full-matrix least-square. Hydrogen
atoms were placed at calculated positions using suitable riding models with isotropic
displacement parameters derived from their carrier atoms. Non-hydrogen atoms were
refined with anisotropic displacement parameters. Atomic scattering factors were taken
from the International Tables for Crystallography volume C.[72] Details of crystal data,
data collection, and structure refinement are listed in the appendix.
2-Chloro-benzo-1,3,2-dithiastibole (26)
1,2-Benzenedithiol (1.00 g, 7.03 mmol) in 10 mL benzene was added drop-wise to
antimony trichloride (1.60 g, 7.01 mmol) in 30 mL benzene at room temperature. The
solution turned yellow upon addition. The solution was stirred for an hour under a
nitrogen atmosphere. Then 15 mL of methanol was added to the solution to dissolve the
solid present. Approximately 10 mL of solvent was then removed via vacuum. Crystals
formed shortly thereafter. The crystals were kept at room temperature. The solution was
filtered and 0.99 g of a crystalline material was obtained with a yield of 47.4 %. Mp:
170.0-172.0 oC. 1H NMR (CDCl3, ppm): δ 7.560 (benzene, m, 2H), δ 7.092 (benzene, m,
2H). 13C NMR (CDCl3, ppm): δ 130.23 (=CH-), δ 125.77 (=CH-). IR (ν, cm-1, KBr):
3045.79 (w), 1942.56 (w), 1909.15 (w), 1790.01 (w), 1603.65 (w), 1549.47 (w), 1442.79
(vs), 1429.02 (w), 1421.04 (s), 1249.39 (m), 1100.26 (m), 1028.58 (m), 940.61 (w),
744.93 (vs), 650.13 (m), 463.08 (m), 426.67 (m). Mass spectra (GC-MS): 261
(SbSC6H4S)+, 185 (SbS2)+, 153 (Sb-S)+.
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Bis(2-(1,3,2-benzodithistibol)-1,2-benzenedithiol (27)
1,2-Benzenedithiol (0.59 g, 4.15 mmol) in 1 mL benzene was added drop-wise to
antimony trifluoride (0.64 g, 3.58 mmol) in 40 mL benzene at room temperature. A
yellow precipitate formed upon addition. The solution was stirred for an hour under a
nitrogen atmosphere. 20 mL of methanol was added to the solution. The solution was
filtered yielding 0.88 g of material with a percent yield of 47.4 %. Mp: 250.0-252.0 oC
Crystals were obtained by re-dissolving the solid in a 70/30 CS2/Benzene solution. The
crystals were kept at room temperature. The crystals are as of yet unsuitable for single
crystal X-ray structure determination. 1H NMR(CS2/CDCl3, ppm, 400 MHz): δ 7.504
(benzene, q, 4H), δ 7.366 (benzene, q, 2H), δ 7.069 (benzene, q, 4H), δ 7.022 (benzene,
q, 2H). 13C NMR (CDCl3, ppm, 100 MHz): δ 132.469 (=CH-), δ 125.448 (=CH-),
δ 94.332 (=CH-). IR (ν, cm-1, KBr): 3422.91 (b), 3046.24 (m), 1927.19 (w), 1626.47 (m),
1548.87 (m), 1439.82 (vs), 1415.63 (s), 1269.15 (w), 1244.67 (m), 1158.23 (w), 1101.55
(m), 1032.68 (m), 931.79 (w), 853.77 (w), 747.30 (vs), 679.50 (w), 653.91 (m),623.19
(w), 470.32 (m), 428.57 (m). Mass spectra (GC-MS): 337 (SbS2C6H4+CS2)+, 261
(SbS2C6H4)+, 108 (SC6H5S)+.
3.4
3.4.1

Results
Synthesis and Spectroscopy
Antimony di- and tri-thiolates are of interest due to their analogous chemistry as

compared to arsenic and their own usefulness in both biological and industrial
environments. Structural representations of the compounds 2-chloro-benzo-1,3,2dithiastibole (26) and bis(2-(1,3,2-benzodithiastibol)-1,2-benzenedithiol (27) are shown
in figure 3.1. The reaction schemes for each synthesis are shown in scheme 3.1.
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There are two phenyl proton signals in the 1H NMR for compound 26, due to the
symmetry of the molecule. In the 13C spectrum, the lack of protons on the carbons
attached to the sulfur reduces the NOE effect and thus those carbons are not seen. The IR
spectrum of 26 shows the corresponding C–S stretches at 650 cm-1, and Sb–S stretches at
463 cm-1 and 427 cm-1 respectively.
In compound 27, the 1H NMR shows four signals that integrate in the ratio 2:1:2:1
between 7.50 and 7.02 ppm, which corresponds to a bridging structure as shown in figure
3.1. The IR spectrum shows the expected ring stretches for the S–Sb–S five membered
ring at 470 and 428 cm-1. The expected C–S stretches at 679 and 654 cm-1 are also seen.
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Figure 3.1. Structural formulae for compounds 26 and 27.

SbCl3 (s)

+

SbCl(SC6H4S) (s) + 2 HCl (g)

HS(C6H4)SH (l)
Benzene

2 SbF3 (s) + 3 HSC6H4SH (l)

(SC6H4S)Sb(SC6H4S)Sb(SC6H4S) (s)
Benzene

+ 6 HF (g)

Scheme 3.1. The synthetic routes to the antimony di- and tri-thiolate compounds.
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3.4.2

Structure
Compound 26 crystallizes in the space group Pbca. The Sb–S bond distances are

approximately 2.41 Å and the Sb–Cl bond distance is 2.46 Å. These values fall in the
expected range for Sb–S and Sb–Cl bonds. Compound 26 has intermolecular Sb…Cl
interactions that are 0.3 Å within the sum of the van der Waals radii. With these contacts
Sb takes on a highly distorted trigonal bypyramidal geometry. The structure of 26 is
shown in figure 3.2. However, a similar reaction in which the Sb-ligand ratio was 1:2,
yielded an antimony (V) derivative bound to three benzenedithiol ligands which has been
structurally characterized.[80] This compound, in which antimony has a coordination
number of six, exists as an anion in the form of ((MeC6H3S2)3Sb)-.
When the Sb–S and Sb–Cl bond lengths in compound 26 are compared to
compound 28 published by Vela et al., which can be seen in figure 3.3, the values are
quite similar and both compounds display secondary interactions within the sum of the
van der Waals radii.[98] This is in keeping with the higher coordination numbers that are
possible for antimony in comparison to arsenic. The Sb–Cl bond distances are
comparable at 2.46 Å in 26 to 2.48 Å in 28. The Sb–S bonds are also very similar at 2.402.41 Å in 26 versus 2.45-2.46 Å in 28. The slightly larger bond lengths for 28 are most
likely due to the larger ring size; a five-membered versus an eight-membered ring.
Crystalline compound 27 was obtained but was not able to be structurally
characterized due to a lack of a crystal of high enough quality. In a previous attempt with
a stoichiometry of 1:1, the intended synthetic compound was a 2-fluoro-benzodithistibane. However, symbiosis makes it much more difficult to stabilize a 2-fluoro
analogue. Once the much softer ligands (sulfurs) form bonds to the antimony, the last Sb–
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F bond becomes extremely labile. The compound has been recrystallized with varying
degrees of success from several solvents including CS2, benzene, CCl4, toluene, CH2Cl2,
CH3OH, and several combinations of these. Unfortunately, at this time a crystal of X-ray
quality has not been obtained.
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Figure 3.2. Molecular structure of 2-chloro-benzo-1,3,2-dithiastibole (26).
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Figure 3.3. Structural formula of compound 28.[98]
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3.5

Conclusion
These compounds shown here provide some new examples of antimony thiolates.

The antimony dithiolate compound (26) is very similar in structural and spectroscopic
characteristics to its arsenic analogue. This can be seen in the Sb–S bond lengths in
comparison to the As–S bond lengths and similarities in S-M-S bond angles where M =
As, Sb. For example, the S–As–S bond angle is 92.94° in 19, whereas in 26, the S–Sb–S
bond angle is 88.39° and the Sb–S bond distances are approximately 0.2 Å longer than
their corresponding As–S bond distances.
The antimony trithiolate is similar to its arsenic analogues in its spectroscopic
characteristics. Compound 27 demonstrates that the antimony trifluoride species is
similarly reactive as its arsenic analogue. Both starting materials yield trithiolates instead
of the 2-fluoro dithiolate analogs. This is most likely due to the M-F bond being labile
and the initial formation of five-membered ring systems which can undergo
intermolecular thiolate-disulfide interchange as reported by Whitesides et al, and
symbiotic interactions.[99] It is interesting to note that to access
((SCH2CH2S)As(SCH2CH2S)As(SCH2CH2S)) 20 involve hydrolytic degradation of the
formed ring. It is speculated by the author that a similar reaction takes place in the
synthesis of compound 27 due to the use of CH3OH as a solvent.

Copyright © Taimur Shaikh 2007

83

Chapter 4

Conclusions and Future Research

4.1 Conclusions
As stated previously, based on the fact that arsenic compounds have biological
activity, it is suggested that novel cyclized arsenic thiolates can be synthesized with the
appropriate characteristics as to be potentially useful as medicinal agents as well as
provide new structural and reaction information for the arsenic thiolate species. The
target compounds are those with arsenic bound by two thiolate groups in a cyclic system
and thus they do not allow the release of arsenic but, with a potentially reactive halide
group, still retain their biological activity by providing a site for glutathione to bind.
What is required is to demonstrate that these compounds can be prepared and that the
dithiolate unit would remain intact under aqueous conditions. This hypothesis was
confirmed in a recent patent where compounds such as S-dimethylarsino-thiosuccinic
acid, S-dimethylarsino-salicylic acid, and S-(dimethylarsino) glutathione were patented
for use as anti-leukemic drugs.[11] In general, the patent was for organic arsenicals
containing an arsenic thiolate.
Methods for administering the compounds of interest have been contemplated.
The more probable applicable administration methods would seem to be direct
administration by injection, intratumoral, and administration to the tumoral vasculature.
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Once the compound is administered in close proximity to the tumor, the halide most
likely will be hydrolyzed and a new As–S bond form. This newly formed bond would
most likely be between the arsenic dithiolate and cysteine or glutathione.
In terms of structural information obtained, compounds 12-19 display an axial
alignment of the halide on the arsenic center with respect to the ring. As can be seen from
the structural data, bond distances and angles are not affected by the identity of the
terminal halide. This explains the spectroscopic similarity between 12, 13, 14 and 19 and
between 15, 16 and 17. Compound 20 seems to be the preferred product in reactions
involving ring breakage of five-membered rings. This is due to the stability of the
trithioarsenic moiety versus a halo-arsenic dithiolate species which plays a large role in
how the reactivity of arsenic dithiolates is assumed to occur. Compound 21 was
synthesized to determine the bond length of the As–S bonds in the absence of a ring
structure yet retaining the electron-withdrawing power of a pseudo-halide. It was thought
that the addition of large electron withdrawing groups would shorten the As–S bond.
Nonetheless, compound 21 exhibits very similar As–S bonds to those in 20. This equates
the pentafluorothiophenyl group in terms of its effect on the arsenic-sulfur bond as to
arsenic-sulfur bonds found in the cyclized arsenic dithiolates. Compound 22
demonstrates intramolecular π-stacking in the solid state. The crystal structure reveals
channels of alternating benzene rings. As a coordinating ligand through the arsenic lone
pairs, or as a basis for metallocenes in molecular self assembly, this molecule has the
correct structure as to be of interesting utility as a ligand which should be assessed in the
near future. Also, compound 22 is the first reported arsenic trithiolate compound with an
intramolecular organic disulfide linkage.
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The compounds reported here provide a basis for comparison with arsenic glutathione
metabolites and of what are up to this point other speculated arsenic thiolate metabolites.
It has been determined that the As–S linkages can be reactive dependent on the As–X
bond and the environmental and biological conditions.
The antimony dithiolate and trithiolate compounds are very similar in structural
and spectroscopic characteristics to their arsenic analogues. This can be seen in the Sb–S
bond lengths in comparison to the As–S bond lengths and similarities in S–M–S bond
angles where M = As, Sb. For example, the S–As–S bond angle is 92.94° in 19, whereas
in 26, the S–Sb–S bond angle is 88.39° and the Sb–S bond distances are approximately
0.2 Å longer than their corresponding As–S bond distances.
Compound 27 demonstrates that the antimony trifluoride species is similarly
reactive as its arsenic analogue. Both starting materials yield trithiolates instead of the 2fluoro-1,3,2-dithiarsenic or antimony analogue. This is most likely due to the M–F bond
being labile and the initial formation of five-membered ring systems which can undergo
intermolecular thiolate-disulfide interchange as reported by Whitesides et al, and
symbiotic interactions.[99]
These compounds provide some new examples of antimony thiolate compounds.
Little is known about the biological activity of such compounds. As has been stated
previously, uses for antimony compounds as an anti-parasitic drug are well known but
with the newly rediscovered efficacy of their arsenic analogues, these antimony
compounds warrant further investigation into the biological properties as well as
continued synthesis of new antimony thiolate compounds for structural information.
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4.2 Future Research
4.2.1

Arsenic Thiolate Interactions in Blood Serum
Now that a series of arsenic dithiolates have been obtained and fully

characterized, it is of interest to explore their aqueous chemistry, especially towards
thiols containing biologically relevant species such as cysteine and glutathione and blood
serum. The pH stability of 12 and 18 has been discussed. Yet, a much more
encompassing investigation would be applicable to ascertain the viability of the 2-halo
arsenic and antimony dithiolates as aqueous stabile compounds stable for medicinal
purposes. Their stability and interactions with other species in blood serum would give
insight into the biological aspects of chelate therapy as such those based on BAL and 2,3dimercaptosuccinic acid as well as in vitro analyses of 2-halo antimony dithiolates for
anti-parasitic activity. Based on what is known about the use of compound 17 in radioisotope labeling, there may be little reactivity of the reported compounds in biologically
relevant aqueous conditions. This is based on the work of Rosch et al. in which they
proposed using compound 17 in vivo. However, the hydrolysis of the 2-halo-arsenic
dithiolates yields arsenic trithiolate species, as well as the original 2-halo dithiolate
analogue. Thus the active compounds in vivo are hydrolyzed derivatives of the starting
compounds. As has been tentatively reported elsewhere in this manuscript, the arsenic
trithiolates are less susceptible to hydrolysis and therefore do not react in water at pH 7.
However, they may still be active.
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4.2.2

Environmental Applications
A water-stable vicinal dithiol could be used as a remediation technology. Polymer

attachment of a vicinal dithiol would make a very strong filtration column for arsenic in
water. Work on just such a system is currently underway in the Atwood group at the
University of Kentucky. However, vicinal dithiols react with several other ions as well.
Thus, a system with some level of ion specificity would need to be devised. The synthesis
of such a system could involve the attachment of BAL or some other vicinal dithiol with
an available –OH to be used to tether the compound to a polymer surface. If the
compound is robust, a dehydration reaction would be a facile means of synthesizing the
polymer.
Alternatively, a vicinal dithiol could be adsorbed onto silica or activated carbon.
This would have similar drawbacks to the polymer-based filtration system but it may be
more facile to synthesize. The synthesis of such a system would involve dissolving the
dithiol and soaking the substrate in a concentrated solution followed by blowing off the
solvent. Then the impregnated silica or activated carbon could be used in a gravity
column.
4.2.3

Solid State 75As NMR
Arsenic only has one stable isotope, 75As. This isotope is NMR active with a

quantum spin number of 3/2 and an NMR receptivity value relative to 13C of 143. The
75

As relative frequency at 7.2 Tesla is 51.391 MHz. There has been very little solid state

75

As NMR done. This may be due to the need for a highly symmetric environment for the

nucleus to obtain resolvable line widths.
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The question of whether arsenic contamination in a given environment is in the
+3 or +5 oxidation states dictates the measures taken under EPA guidelines. Therefore,
there may be application for this technique in the speciation of a solid compound. The
application for such a technology would have a large impact on remediation measures
taken. To this end, we are currently seeking a collaborator to undertake this aspect of the
research.
4.2.4

Activity of Cyclized Arsenic Thiolates Towards Leukemic Cells
With the recent publication of several compounds sharing structural similarities

with the reported compounds, it would be prudent to take several of the synthesized
compounds and test for antileukemic activity.[2, 4-10] This could be done in collaboration
with groups already active in the field such as John Yannelli, an associate professor of
internal medicine who is currently working on gene therapy for leukemia at the
University of Kentucky. Also, it has been seen in the literature that antimony and bismuth
complexes similar to the arsenic compounds reported here may have some medicinal uses
as anti-parasitic compounds.
4.2.5

Bismuth Dithiolate Chemistry
Bismuth analogues of the series of compounds discussed here exist for some

particular compounds such as the Bi analogues to 12, 13, 19, and 26. However, several
more have not been synthesized such as the bismuth analogue of compounds 22 and 27. It
would be beneficial to continue of this work with bismuth. Bismuth chemistry is strongly
influenced by the lanthanide contraction.
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The lanthanide contraction is the weaker shielding of the nucleus by the f-orbitals
electrons due to the directionality of said orbitals. The s-orbitals are localized at the
nucleus, thus experiencing a stronger attractive effect. The lanthanide contraction plays
an important role in the availability of the Bi (III) oxidation state in dithiolate chemistry.
In essence, the perceived nuclear charge is higher than it ought to be. This leads to a
much stronger attraction between the outer electrons and the nucleus, making it harder to
oxidize the element. Also, the s-p orbital splitting increases as the size of the nucleus
increases which is exacerbated by the lanthanide contraction, thus making these
compound an interesting group to study.
The reactivity of bismuth is considerably lower than that of arsenic and antimony.
Therefore, other more energetic techniques may be required such as reflux and the
inclusion of base to deprotonate the thiols in a reaction with BiCl3. One such reaction
could involve the use of sodium ethoxide to accomplish the deprotonation of a
stoichiometric ratio of 3:1 benzene-1,2-dithiol and BiCl3.
4.2.6

Use as Ligands
The metal coordinated 2-methyl-1,3,2-dithiarsolanes have been synthesized but

there has been no structural characterization of this class of compounds.[88] The metalarsenic bond lengths can be estimated in such a system yet a structural determination of a
representative compound would be definitive. As such, a need for the structural
determination of such a compound exists.

Copyright © Taimur Shaikh 2007
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Figure A1. Packing diagram for 2-chloro-1,3,2-dithiarsolane (12). Hydrogen atoms are
omitted for clarity.
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Table A2. Crystal data and structure refinement for 2-chloro-1,3,2-dithiarsolane (12)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 25.00
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole

2-chloro-1,3,2-dithiarsolane
C2H4AsClS2
202.54
90.0(2)
0.71073
Monoclinic
P21/c
9.7563(2)
7.0930(1)
9.2864(2)
90
111.9504(9)
90
596.05(2)
4
2.257
6.702
392
0.25 x 0.20 x 0.15
2.25 to 25.00
-11 ≤ h ≤ 11, -8 ≤ k ≤ 8, -10 ≤ l ≤ 11
1979
1058 [R(int) = 0.0198]
100.0 %
Semi-empirical from equivalents
0.4330 and 0.2851
Full-matrix least-squares on F2
1058 / 0 / 56
1.086
R1 = 0.0142, wR2 = 0.0313
R1 = 0.0156, wR2 = 0.0318
0.0133(6)
0.229 and -0.381 e.A-3
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Table A3. Bond lengths (Å) and angles (°) for 2-chloro-1,3,2-dithiarsolane (12)
Atoms

Bond lengths (Å)

As(1)-S(2)
As(1)-S(1)
As(1)-Cl(1)
S(1)-C(1)
S(2)-C(2)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-H(2A)
C(2)-H(2B)

2.2088(5)
2.2402(5)
2.2669(4)
1.8343(19)
1.8193(18)
1.505(2)
0.9900
0.9900
0.9900
0.9900

Atoms

Bond angles (°)

S(2)-As(1)-S(1)
S(2)-As(1)-Cl(1)
S(1)-As(1)-Cl(1)
C(1)-S(1)-As(1)
C(2)-S(2)-As(1)
C(2)-C(1)-S(1)
C(2)-C(1)-H(1A)
S(1)-C(1)-H(1A)
C(2)-C(1)-H(1B)
S(1)-C(1)-H(1B)
H(1A)-C(1)-H(1B)
C(1)-C(2)-S(2)
C(1)-C(2)-H(2A)
S(2)-C(2)-H(2A)
C(1)-C(2)-H(2B)
S(2)-C(2)-H(2B)
H(2A)-C(2)-H(2B)

93.398(18)
98.857(17)
97.445(18)
100.45(6)
96.81(6)
111.35(13)
109.4
109.4
109.4
109.4
108.0
110.49(12)
109.6
109.6
109.6
109.6
108.1
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Figure A4. Packing diagram for 2-bromo-1,3,2-dithiarsolane (13). Hydrogen atoms are
omitted for clarity.
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Table A5. Crystal data and structure refinement for 2-bromo-1,3,2-dithiarsolane (13)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 25.00
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Absolute structure coefficient
Extinction coefficient
Largest diff. peak and hole

2-bromo-1,3,2-dithiarsolane
C2H4AsBrS2
247.00
90.0(2)
0.71073
Orthorhombic
P212121
6.7428(1)
9.5235(1)
9.5753(1)
90
90
90
614.878(13)
4
2.668
12.562
464
0.23 x 0.22 x 0.20
3.02 to 27.48
-8 ≤ h ≤ 8, -12 ≤ k ≤ 12, -12 ≤ l ≤ 12
1405
1405 [R(int) = 0.0590]
100.0 %
Semi-empirical from equivalents
0.188 and 0.162
Full-matrix least-squares on F2
1405 / 0 / 56
1.121
R1 = 0.0131, wR2 = 0.0324
R1 = 0.0131, wR2 = 0.0324
0.028(8)
0.0122(6)
0.324 and -0.266 e.A-3
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Table A6. Bond lengths (Å) and angles (°) for 2-bromo-1,3,2-dithiarsolane (13)
Atoms

Bond lengths (Å)

Br(1)-As(1)
As(1)-S(1)
As(1)-S(2)
S(1)-C(1)
S(2)-C(2)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-H(2A)
C(2)-H(2B)

2.4196(3)
2.2092(6)
2.2278(6)
1.820(2)
1.829(2)
1.513(3)
0.9900
0.9900
0.9900
0.9900

Atoms

Bond angles (°)

S(1)-As(1)-S(2)
S(1)-As(1)-Br(1)
S(2)-As(1)-Br(1)
C(1)-S(1)-As(1)
C(2)-S(2)-As(1)
C(2)-C(1)-S(1)
C(2)-C(1)-H(1A)
S(1)-C(1)-H(1A)
C(2)-C(1)-H(1B)
S(1)-C(1)-H(1B)
H(1A)-C(1)-H(1B)
C(1)-C(2)-S(2)
C(1)-C(2)-H(2A)
S(2)-C(2)-H(2A)
C(1)-C(2)-H(2B)
S(2)-C(2)-H(2B)
H(2A)-C(2)-H(2B)

94.03(2)
99.449(18)
97.948(18)
96.91(8)
100.52(7)
110.75(16)
109.5
109.5
109.5
109.5
108.1
111.33(15)
109.4
109.4
109.4
109.4
108.0
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Figure A7. Packing diagram for 2-iodo-1,3,2-dithiarsolane (14). Hydrogen atoms are
omitted for clarity.
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Table A8. Crystal data and structure refinement for 2-iodo-1,3,2-dithiarsolane (14)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 27.45
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole

2-iodo-1,3,2-dithiarsolane
C2H4AsIS2
203.99
90.0(2)
0.71073
Monoclinic
Cc
9.9446(3)
9.8158(3)
13.6402(4)
90
100.1139(12)
90
1310.79(7)
8
2.979
10.400
1072
0.15 x 0.12 x 0.12
2.94 to 27.45
-12 ≤ h ≤ 12, -12 ≤ k ≤ 12, -17 ≤ l ≤ 17
2775
2772 [R(int) = 0.0106]
100.0 %
Semi-empirical from equivalents
0.3684 and 0.3045
Full-matrix least-squares on F2
2772 / 2 / 110
1.022
R1 = 0.0228, wR2 = 0.0416
R1 = 0.0274, wR2 = 0.0429
0.00073(5)
.583 and -.559 e.A-3
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Table A9. Bond lengths (Å) and angles (°) for 2-iodo-1,3,2-dithiarsolane (14)
Atoms

Bond lengths (Å)

As(1A)-S(1A)
As(1A)-S(2A)
As(1A)-I(1A)
S(1A)-C(1A)
S(2A)-C(2A)
C(1A)-C(2A)
C(1A)-H(1A1)
C(1A)-H(1A2)
C(2A)-H(2A1)
C(2A)-H(2A2)
As(1B)-S(2B)
As(1B)-S(1B)
As(1B)-I(1B)
S(1B)-C(1B)
S(2B)-C(2B)
C(1B)-C(2B)
C(1B)-H(1B1)
C(1B)-H(1B2)
C(2B)-H(2B1)
C(2B)-H(2B2)

2.2119(19)
2.2311(17)
2.6502(7)
1.817(5)
1.825(5)
1.522(6)
0.9900
0.9900
0.9900
0.9900
2.2162(17)
2.2312(19)
2.6474(7)
1.816(6)
1.822(5)
1.507(6)
0.9900
0.9900
0.9900
0.9900

Atoms

Bond angles (°)

S(1A)-As(1A)-S(2A)
S(1A)-As(1A)-I(1A)
S(2A)-As(1A)-I(1A)
C(1A)-S(1A)-As(1A)
C(2A)-S(2A)-As(1A)
C(2A)-C(1A)-S(1A)
C(2A)-C(1A)-H(1A1)
S(1A)-C(1A)-H(1A1)
C(2A)-C(1A)-H(1A2)
S(1A)-C(1A)-H(1A2)
H(1A1)-C(1A)-H(1A2)
C(1A)-C(2A)-S(2A)
C(1A)-C(2A)-H(2A1)
S(2A)-C(2A)-H(2A1)
C(1A)-C(2A)-H(2A2)
S(2A)-C(2A)-H(2A2)
H(2A1)-C(2A)-H(2A2)

93.20(7)
99.80(5)
100.56(5)
97.39(17)
101.27(16)
110.6(3)
109.5
109.5
109.5
109.5
108.1
112.2(3)
109.2
109.2
109.2
109.2
107.9
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S(2B)-As(1B)-S(1B)
S(2B)-As(1B)-I(1B)
S(1B)-As(1B)-I(1B)
C(1B)-S(1B)-As(1B)
C(2B)-S(2B)-As(1B)
C(2B)-C(1B)-S(1B)
C(2B)-C(1B)-H(1B1)
S(1B)-C(1B)-H(1B1)
C(2B)-C(1B)-H(1B2)
S(1B)-C(1B)-H(1B2)
H(1B1)-C(1B)-H(1B2)
C(1B)-C(2B)-S(2B)
C(1B)-C(2B)-H(2B1)
S(2B)-C(2B)-H(2B1)
C(1B)-C(2B)-H(2B2)
S(2B)-C(2B)-H(2B2)
H(2B1)-C(2B)-H(2B2)

93.23(7)
99.65(5)
100.80(5)
101.26(18)
97.15(18)
112.4(3)
109.1
109.1
109.1
109.1
107.9
111.0(4)
109.4
109.4
109.4
109.4
108.0
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Figure A10. Packing diagram for 2-chloro-1,3,2-dithiarsenane (15). Hydrogen atoms are
omitted for clarity.

104

Table A11. Crystal data and structure refinement for 2-chloro-1,3,2-dithiarsenane (15)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 24.99
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Largest diff. peak and hole

2-chloro-1,3,2-dithiarsenane
C3H6AsClS2
216.5 7
90.0(2) K
0.71073
Orthorhombic
Pnma
9.9720(5)
9.7510(4)
7.0530(6)
90
90
90
685.81(7)
4
2.097
5.833
424
0.15 x 0.15 x 0.05
3.54 to 24.99
-11 ≤ h ≤ 11, -11 ≤ k ≤ 11, -7 ≤ l ≤ 8
2212
650 [R(int) = 0.0375]
100.0 %
Semi-empirical from equivalents
0.7591 and 0.4749
Full-matrix least-squares on F2
650 / 0 / 37
1.202
R1 = 0.0267, wR2 = 0.0621
R1 = 0.0293, wR2 = 0.0630
0.452 and -0.750 e.A-3

105

Table A12. Bond lengths (Å) and angles (°) for 2-chloro-1,3,2-dithiarsenane (15)
Atoms

Bond lengths (Å)

As(1)-S(1)
As(1)-S(1)#1
As(1)-Cl(1)
S(1)-C(1)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-C(1)#1
C(2)-H(2A)
C(2)-H(2B)

2.2188(9)
2.2189(9)
2.2328(13)
1.830(4)
1.518(4)
0.9900
0.9900
1.518(4)
0.9900
0.9900

Atoms

Bond angles (°)

S(1)-As(1)-S(1)#1
102.20(5)
S(1)-As(1)-Cl(1)
98.32(3)
S(1)#1-As(1)-Cl(1)
98.32(3)
C(1)-S(1)-As(1)
104.28(12)
C(2)-C(1)-S(1)
115.8(3)
C(2)-C(1)-H(1A)
108.3
S(1)-C(1)-H(1A)
108.3
C(2)-C(1)-H(1B)
108.3
S(1)-C(1)-H(1B)
108.3
H(1A)-C(1)-H(1B)
107.4
C(1)-C(2)-C(1)#1
115.4(4)
C(1)-C(2)-H(2A)
108.4
C(1)#1-C(2)-H(2A)
108.4
C(1)-C(2)-H(2B)
108.4
C(1)#1-C(2)-H(2B)
108.4
H(2A)-C(2)-H(2B)
107.5
Symmetry transformations used to generate equivalent atoms: #1 x,-y+1/2,z
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Figure A13. Packing diagram for 2-bromo-1,3,2-dithiarsenane (16). Hydrogen atoms are
omitted for clarity.
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Table A14. Crystal data and structure refinement for 2-bromo-1,3,2-dithiarsenane (16)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 24.99
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole

2-bromo-1,3,2-dithiarsenane
C3H6AsBrS2
261.03
90.0(2) K
0.71073
Monoclinic
P21/c
8.7723(1)
6.8078(1)
11.9217(2)
90
93.6077(6)
90
710.554(18)
4
2.440
10.877
496
0.18 x 0.15 x 0.08
2.33 to 27.47
-11 ≤ h ≤ 11, -8 ≤ k ≤ 8, -15 ≤ l ≤ 15
3133
1636 [R(int) = 0.0146]
100.0 %
Semi-empirical from equivalents
0.4765 and 0.2449
Full-matrix least-squares on F2
1636 / 0 / 65
1.077
R1 = 0.0149, wR2 = 0.0341
R1 = 0.0164, wR2 = 0.0347
0.0079(3)
0.334 and -0.375 e.A-3
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Table A15. Bond lengths (Å) and angles (°) for 2-bromo-1,3,2-dithiarsenane (16)
Atoms

Bond lengths (Å)

As(1)-S(1)
As(1)-S(2)
As(1)-Br(1)
S(1)-C(1)
S(2)-C(3)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-C(3)
C(2)-H(2A)
C(2)-H(2B)
C(3)-H(3A)
C(3)-H(3B)

2.2226(5)
2.2284(5)
2.3901(2)
1.8247(18)
1.8237(18)
1.519(2)
0.9900
0.9900
1.525(2)
0.9900
0.9900
0.9900
0.9900

Atoms

Bond angles (°)

S(1)-As(1)-S(2)
S(1)-As(1)-Br(1)
S(2)-As(1)-Br(1)
C(1)-S(1)-As(1)
C(3)-S(2)-As(1)
C(2)-C(1)-S(1)
C(2)-C(1)-H(1A)
S(1)-C(1)-H(1A)
C(2)-C(1)-H(1B)
S(1)-C(1)-H(1B)
H(1A)-C(1)-H(1B)
C(1)-C(2)-C(3)
C(1)-C(2)-H(2A)
C(3)-C(2)-H(2A)
C(1)-C(2)-H(2B)
C(3)-C(2)-H(2B)
H(2A)-C(2)-H(2B)
C(2)-C(3)-S(2)
C(2)-C(3)-H(3A)
S(2)-C(3)-H(3A)
C(2)-C(3)-H(3B)
S(2)-C(3)-H(3B)
H(3A)-C(3)-H(3B)

100.595(17)
99.199(14)
99.612(14)
105.27(6)
104.45(6)
116.01(12)
108.3
108.3
108.3
108.3
107.4
114.38(14)
108.7
108.7
108.7
108.7
107.6
115.50(13)
108.4
108.4
108.4
108.4
107.5
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Figure A16. Packing diagram for 2-iodo-1,3,2-dithiarsenane (17). Hydrogen atoms are
omitted for clarity.
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Table A17. Crystal data and structure refinement for 2-iodo-1,3,2-dithiarsenane (17)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 27.49
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole

2-iodo-1,3,2-dithiarsenane
C3H6AsIS2
308.02
90.0(2) K
0.71073
Monoclinic
P21/n
7.3970(2)
12.9494(3)
8.0262(2)
90
101.1213(10)
90
754.37(3)
4
2.712
9.042
568
0.15 x 0.14 x 0.10
3.03 to 27.49
-9 ≤ h ≤ 9, -16 ≤ k ≤ 16, -10 ≤ l ≤ 10
3386
1735 [R(int) = 0.0200]
99.9 %
Semi-empirical from equivalents
0.4650 and 0.3441
Full-matrix least-squares on F2
1735 / 0 / 68
1.076
R1 = 0.0186, wR2 = 0.0383
R1 = 0.0232, wR2 = 0.0397
0.0034(2)
.717 and -.704 e.A-3
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Table A18. Bond lengths (Å) and angles (°) for 2-iodo-1,3,2-dithiarsenane (17)
Atoms

Bond lengths (Å)

I(1)-As(1)
As(1)-S(2)
As(1)-S(1)
S(1)-C(1)
S(2)-C(3)
C(3)-C(2)
C(3)-H(3A)
C(3)-H(3B)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-H(2A)
C(2)-H(2B)

2.6036(3)
2.2215(7)
2.2252(7)
1.823(3)
1.828(3)
1.519(3)
0.9697
0.9697
1.517(4)
0.9762
0.9762
0.9943
0.9943

Atoms

Bond angles (°)

S(2)-As(1)-S(1)
S(2)-As(1)-I(1)
S(1)-As(1)-I(1)
C(1)-S(1)-As(1)
C(3)-S(2)-As(1)
C(2)-C(3)-S(2)
C(2)-C(3)-H(3A)
S(2)-C(3)-H(3A)
C(2)-C(3)-H(3B)
S(2)-C(3)-H(3B)
H(3A)-C(3)-H(3B)
C(2)-C(1)-S(1)
C(2)-C(1)-H(1A)
S(1)-C(1)-H(1A)
C(2)-C(1)-H(1B)
S(1)-C(1)-H(1B)
H(1A)-C(1)-H(1B)
C(1)-C(2)-C(3)
C(1)-C(2)-H(2A)
C(3)-C(2)-H(2A)
C(1)-C(2)-H(2B)
C(3)-C(2)-H(2B)
H(2A)-C(2)-H(2B)

101.42(3)
100.624(19)
100.87(2)
105.42(9)
104.69(9)
116.70(19)
108.1
108.1
108.1
108.1
107.3
115.42(19)
108.4
108.4
108.4
108.4
107.5
115.2(2)
108.5
108.5
108.5
108.5
107.5
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Figure A19. Packing diagram for 3-chloro-4H,7H-5,6-benz-1,3,2-dithiarsepine (18).
Hydrogen atoms are omitted for clarity.
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Table A20. Crystal data and structure refinement for 3-chloro-4H,7H-5,6-benz-1,3,2dithiarsepine (18)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 27.48
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole

3-chloro-4H,7H-5,6-benz-1,3,2dithiarsepine
C8H8AsClS2
278.63
90.0(2)
0.71073
Orthorhombic
Pnma
9.5439(3)
9.9009(3)
10.4746(3)
90
90
90
989.78(5)
4
1.870
4.065
552
0.15 x 0.15 x 0.15
2.83 to 27.48
-12<=h<=12, -12<=k<=12, -13<=l<=13
2155
1208 [R(int) = 0.0230]
100.0 %
Semi-empirical from equivalents
0.5807 and 0.5807
Full-matrix least-squares on F2
1208 / 0 / 59
1.099
R1 = 0.0231, wR2 = 0.0503
R1 = 0.0321, wR2 = 0.0530
0.0032(5)
.434 and -.405 e.A-3
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Table A21. Bond lengths (Å) and angles (°) for 3-chloro-4H,7H-5,6-benz-1,3,2dithiarsepine (18)
Atoms

Bond lengths (Å)

As(1)-S(1)#1
As(1)-S(1)
As(1)-Cl(1)
S(1)-C(1)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-C(3)
C(2)-C(2)#1
C(3)-C(4)
C(3)-H(3)
C(4)-C(4)#1
C(4)-H(4)

2.2316(5)
2.2317(5)
2.2351(8)
1.8325(19)
1.507(3)
0.9900
0.9900
1.396(3)
1.406(4)
1.389(3)
0.9500
1.382(4)
0.9500

Atoms

Bond angles (°)

S(1)#1-As(1)-S(1)
105.06(3)
S(1)#1-As(1)-Cl(1)
97.842(19)
S(1)-As(1)-Cl(1)
97.842(19)
C(1)-S(1)-As(1)
108.01(7)
C(2)-C(1)-S(1)
113.39(13)
C(2)-C(1)-H(1A)
108.9
S(1)-C(1)-H(1A)
108.9
C(2)-C(1)-H(1B)
108.9
S(1)-C(1)-H(1B)
108.9
H(1A)-C(1)-H(1B)
107.7
C(3)-C(2)-C(2)#1
119.26(12)
C(3)-C(2)-C(1)
118.85(17)
C(2)#1-C(2)-C(1)
121.87(11)
C(4)-C(3)-C(2)
120.75(19)
C(4)-C(3)-H(3)
119.6
C(2)-C(3)-H(3)
119.6
C(4)#1-C(4)-C(3)
119.97(12)
C(4)#1-C(4)-H(4)
120.0
C(3)-C(4)-H(4)
120.0
Symmetry transformations used to generate equivalent atoms: #1 x,-y+1/2,z
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Figure A22. Packing diagram for 2-chloro-benzo-1,3,2-dithiarsole (19). Hydrogen atoms
are omitted for clarity.
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Table A23. Crystal data and structure refinement for 2-chloro-benzo-1,3,2-dithiarsole
(19). However, the refinement can not be completed.
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 25.00
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole

2-chloro-benzo-1,3,2-dithiarsole
C6H4AsClS2
250.60
90.0(2)
0.71073
Triclinic
_

P1
12.3533(2)
22.3789(3)
26.6255(5)
76.7415(7)
80.0542(8)
76.8076(7)
6918.93
34
2.045
4148
-14 ≤ h ≤14, -26 ≤ k ≤ 26, -31 ≤ l ≤ 31
24396
8774 [R(int) = 0.0804]
Semi-empirical from equivalents
Full-matrix least-squares on F2
24396/4590/1531
0.922
R1 = 0.0367, wR2 = 0.0706
R1 = 0.1351, wR2 = 0.0961
0..494 and -.675 e.A-3
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Table A24. Bond lengths (Å) and angles (°) for 2-chloro-benzo-1,3,2-dithiarsole (19) The
bond lengths are averaged across the unsymmetrical unit. The bond angles were taken
from a representative molecule (J).
Atoms

Bond lengths (Å)

As(1)-S(1)
As(1)-S(2)
As(1)-Cl(1)
S(1)-C(1)
S(2)-C(6)
C(1)-C(2)
C(2)-C(3)
C(3)-C(4)
C(4)-C(5)
C(5)-C(6)
C(1)-C(6)
C(2)-H(2)
C(3)-H(3)
C(4)-H(4)
C(5)-H(5)

2.209471
2.209765
2.290294
1.756059
1.771059
1.391529
1.378176
1.386235
1.376529
1.394588
1.396353
0.950235
0.950176
0.9500
0.949824

Atoms

Bond angles (°)

S(1)-As(1)-S(2)
S(1)-As(1)-Cl(1)
S(2)-As(1)-Cl(1)
C(6)-S(2)-As(1)
C(1)-S(1)-As(1)
C(5)-C(6)-S(2)
C(2)-C(1)-S(1)
S(2)-C(6)-C(1)
S(1)-C(1)-C(6)
C(1)-C(2)-C(3)
C(2)-C(3)-C(4)
C(3)-C(4)-C(5)
C(4)-C(5)-C(6)
C(5)-C(6)-C(1)
C(6)-C(1)-C(2)
C(1)-C(2)-H(2)
C(2)-C(3)-H(3)
C(3)-C(4)-H(4)

93.52
100.25
99.68
101.12
101.48
119.16
118.48
120.61
121.65
119.45
120.29
121.13
118.94
120.20
119.75
120.19
119.71
119.45
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C(4)-C(5)-H(5)
H(2)-C(2)-C(3)
H(3)-C(3)-C(4)
H(4)-C(4)-C(5)
H(5)-C(5)-C(6)

120.49
120.36
120.01
119.42
120.57
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Figure A25. Packing diagram for 1,2-bis-dithiarsolan-2-ylmercapto-ethane (20).
Hydrogen atoms are omitted for clarity.
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Table A26. Crystal data and structure refinement for 1,2-bis-dithiarsolan-2-ylmercaptoethane (20)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 25.34
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole

1,2-bis-dithiarsolan-2-ylmercapto-ethane
C3H6AsS3
213.18
90.0(2)
0.71073
Orthorhombic
P212121
5.0916(1)
10.2877(3)
26.2326(8)
90
90
90
1374.09(6)
8
2.061
5.737
840
0.28 x 0.08 x 0.01
1.55 to 25.34
-6 ≤ h ≤ 6, -12 ≤ k ≤ 12, -31 ≤ l ≤ 31
2514
2514 [R(int) = 0.0890]
100.0 %
Semi-empirical from equivalents
0.9449 and 0.2965
Full-matrix least-squares on F2
2514 / 0 / 127
0.983
R1 = 0.0368, wR2 = 0.0701
R1 = 0.0566, wR2 = 0.0762
-0.005(14)
.675 and -.522 e.A-3
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Table A27. Bond lengths (Å) and angles (°) for 1,2-bis-dithiarsolan-2-ylmercapto-ethane
(20)
Atoms

Bond lengths (Å)

As(1)-S(1)
As(1)-S(2)
As(1)-S(3)
As(2)-S(5)
As(2)-S(6)
As(2)-S(4)
S(1)-C(1)
S(2)-C(2)
S(3)-C(3)
S(4)-C(4)
S(5)-C(5)
S(6)-C(6)
C(1)-C(2)
C(1)-H(1A)
C(1)-H(1B)
C(2)-H(2A)
C(2)-H(2B)
C(3)-C(4)
C(3)-H(3A)
C(3)-H(3B)
C(4)-H(4A)
C(4)-H(4B)
C(5)-C(6)
C(5)-H(5A)
C(5)-H(5B)
C(6)-H(6A)
C(6)-H(6B)

2.2315(17)
2.2472(16)
2.2610(17)
2.2311(16)
2.2452(16)
2.2683(16)
1.810(6)
1.835(6)
1.838(6)
1.817(5)
1.820(6)
1.832(6)
1.509(7)
0.9900
0.9900
0.9900
0.9900
1.510(8)
0.9900
0.9900
0.9900
0.9900
1.518(8)
0.9900
0.9900
0.9900
0.9900

Atoms

Bond angles (°)

S(1)-As(1)-S(2)
S(1)-As(1)-S(3)
S(2)-As(1)-S(3)
S(5)-As(2)-S(6)
S(5)-As(2)-S(4)
S(6)-As(2)-S(4)
C(1)-S(1)-As(1)
C(2)-S(2)-As(1)

93.24(6)
102.15(6)
94.33(6)
93.86(6)
99.46(6)
93.21(6)
95.77(19)
100.3(2)
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C(3)-S(3)-As(1)
C(4)-S(4)-As(2)
C(5)-S(5)-As(2)
C(6)-S(6)-As(2)
C(2)-C(1)-S(1)
C(2)-C(1)-H(1A)
S(1)-C(1)-H(1A)
C(2)-C(1)-H(1B)
S(1)-C(1)-H(1B)
H(1A)-C(1)-H(1B)
C(1)-C(2)-S(2)
C(1)-C(2)-H(2A)
S(2)-C(2)-H(2A)
C(1)-C(2)-H(2B)
S(2)-C(2)-H(2B)
H(2A)-C(2)-H(2B)
C(4)-C(3)-S(3)
C(4)-C(3)-H(3A)
S(3)-C(3)-H(3A)
C(4)-C(3)-H(3B)
S(3)-C(3)-H(3B)
H(3A)-C(3)-H(3B)
C(3)-C(4)-S(4)
C(3)-C(4)-H(4A)
S(4)-C(4)-H(4A)
C(3)-C(4)-H(4B)
S(4)-C(4)-H(4B)
H(4A)-C(4)-H(4B)
C(6)-C(5)-S(5)
C(6)-C(5)-H(5A)
S(5)-C(5)-H(5A)
C(6)-C(5)-H(5B)
S(5)-C(5)-H(5B)
H(5A)-C(5)-H(5B)
C(5)-C(6)-S(6)
C(5)-C(6)-H(6A)
S(6)-C(6)-H(6A)
C(5)-C(6)-H(6B)
S(6)-C(6)-H(6B)
H(6A)-C(6)-H(6B)

97.5(2)
97.52(19)
95.8(2)
99.6(2)
110.9(4)
109.5
109.5
109.5
109.5
108.1
110.9(4)
109.5
109.5
109.5
109.5
108.0
113.0(4)
109.0
109.0
109.0
109.0
107.8
112.8(4)
109.0
109.0
109.0
109.0
107.8
109.9(4)
109.7
109.7
109.7
109.7
108.2
112.4(4)
109.1
109.1
109.1
109.1
107.9
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Figure A28. Packing diagram for tris-(pentafluorophenylthio)-arsen (21).
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Table A29. Crystal data and structure refinement for tris-(pentafluorophenylthio)-arsen
(21)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 27.50
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole

tris-(pentafluorophenylthio)-arsen
C18AsF15S3
672.28
90.0(2)
0.71073
Orthorhombic
Fdd2
32.5222(1)
46.8717(4)
5.5499(6)
90
90
90
8460.1(9)
16
2.111
2.042
5184
0.25 x 0.10 x 0.08
1.52 to 27.50
-41 ≤ h ≤ 42, -59 ≤ k ≤ 60, -7 ≤ l ≤ 7
4794
4794 [R(int) = 0.079]
100.0 %
Semi-empirical from equivalents
0.8619 and 0.6293
Full-matrix least-squares on F2
4794 / 1 / 335
1.028
R1 = 0.0349, wR2 = 0.0853
R1 = 0.0457, wR2 = 0.0906
0.455(9)
.675 and -.547 e.A-3
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Table A30. Bond lengths (Å) and angles (°) for tris-(pentafluorophenylthio)-arsen (21)
Atoms

Bond lengths (Å)

As(1)-S(3)
As(1)-S(2)
As(1)-S(1)
S(1)-C(1)
S(2)-C(7)
S(3)-C(13)
C(1)-C(6)
C(1)-C(2)
C(2)-F(1)
C(2)-C(3)
C(3)-F(2)
C(3)-C(4)
C(4)-F(3)
C(4)-C(5)
C(5)-F(4)
C(5)-C(6)
C(6)-F(5)
C(7)-C(8)
C(7)-C(12)
C(8)-F(6)
C(8)-C(9)
C(9)-F(7)
C(9)-C(10)
C(10)-F(8)
C(10)-C(11)
C(11)-F(9)
C(11)-C(12)
C(12)-F(10)
C(13)-C(14)
C(13)-C(18)
C(14)-F(11)
C(14)-C(15)
C(15)-F(12)
C(15)-C(16)
C(16)-F(13)
C(16)-C(17)
C(17)-F(14)
C(17)-C(18)
C(18)-F(15)

2.2585(10)
2.2622(11)
2.2660(10)
1.767(4)
1.771(4)
1.751(4)
1.370(6)
1.397(5)
1.336(5)
1.381(5)
1.345(4)
1.366(6)
1.335(5)
1.382(5)
1.350(5)
1.367(6)
1.349(4)
1.379(6)
1.380(6)
1.333(4)
1.382(5)
1.341(5)
1.369(6)
1.332(5)
1.385(7)
1.341(5)
1.371(7)
1.333(5)
1.391(5)
1.399(5)
1.335(5)
1.378(7)
1.342(5)
1.363(6)
1.342(5)
1.364(6)
1.333(5)
1.381(6)
1.334(4)
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Atoms

Bond angles (°)

S(3)-As(1)-S(2)
S(3)-As(1)-S(1)
S(2)-As(1)-S(1)
C(1)-S(1)-As(1)
C(7)-S(2)-As(1)
C(13)-S(3)-As(1)
C(6)-C(1)-C(2)
C(6)-C(1)-S(1)
C(2)-C(1)-S(1)
F(1)-C(2)-C(3)
F(1)-C(2)-C(1)
C(3)-C(2)-C(1)
F(2)-C(3)-C(4)
F(2)-C(3)-C(2)
C(4)-C(3)-C(2)
F(3)-C(4)-C(3)
F(3)-C(4)-C(5)
C(3)-C(4)-C(5)
F(4)-C(5)-C(6)
F(4)-C(5)-C(4)
C(6)-C(5)-C(4)
F(5)-C(6)-C(5)
F(5)-C(6)-C(1)
C(5)-C(6)-C(1)
C(8)-C(7)-C(12)
C(8)-C(7)-S(2)
C(12)-C(7)-S(2)
F(6)-C(8)-C(7)
F(6)-C(8)-C(9)
C(7)-C(8)-C(9)
F(7)-C(9)-C(10)
F(7)-C(9)-C(8)
C(10)-C(9)-C(8)
F(8)-C(10)-C(9)
F(8)-C(10)-C(11)
C(9)-C(10)-C(11)
F(9)-C(11)-C(12)
F(9)-C(11)-C(10)
C(12)-C(11)-C(10)
F(10)-C(12)-C(11)
F(10)-C(12)-C(7)
C(11)-C(12)-C(7)
C(14)-C(13)-C(18)

98.53(4)
98.31(4)
87.82(4)
96.93(13)
97.66(13)
100.52(13)
117.1(4)
122.3(3)
120.6(3)
118.0(3)
120.8(4)
121.2(4)
119.6(4)
120.3(4)
120.1(4)
120.3(4)
120.3(4)
119.4(4)
121.0(3)
119.1(3)
120.0(4)
117.8(4)
120.0(4)
122.3(4)
117.6(4)
121.4(3)
120.9(3)
120.9(3)
117.8(4)
121.3(4)
119.4(4)
120.3(4)
120.3(4)
120.5(4)
120.4(4)
119.1(4)
120.3(5)
119.7(4)
120.0(4)
118.5(4)
119.8(4)
121.7(4)
115.9(4)
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C(14)-C(13)-S(3)
C(18)-C(13)-S(3)
F(11)-C(14)-C(15)
F(11)-C(14)-C(13)
C(15)-C(14)-C(13)
F(12)-C(15)-C(16)
F(12)-C(15)-C(14)
C(16)-C(15)-C(14)
F(13)-C(16)-C(15)
F(13)-C(16)-C(17)
C(15)-C(16)-C(17)
F(14)-C(17)-C(16)
F(14)-C(17)-C(18)
C(16)-C(17)-C(18)
F(15)-C(18)-C(17)
F(15)-C(18)-C(13)
C(17)-C(18)-C(13)

121.6(3)
122.3(3)
118.4(4)
119.3(4)
122.3(4)
120.7(4)
119.7(4)
119.7(4)
120.0(4)
119.3(4)
120.5(4)
120.0(4)
120.2(4)
119.7(4)
118.9(4)
119.3(4)
121.8(4)
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Figure A31. Packing diagram for bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)benzenesulfide) (22). Hydrogen atoms are omitted for clarity.
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Table A32. Crystal data and structure refinement for bis(2-(1,3,2-benzodithiarsol2ylsulfanyl)-benzenesulfide) (22)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 68.04
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Largest diff. peak and hole

bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)benzenesulfide)
C24H16As2S8
710.69
90.0(2)
1.54178
Monoclinic
C2/c
24.3415(4)
12.8324(2)
8.7729(2)
90
109.440(1)
90
2584.08(8)
4
1.827
9.366
1416
0.09 x 0.04 x 0.01
3.85 to 68.04
-29 ≤ h ≤ 29, -15 ≤ k ≤ 15, -7 ≤ l ≤ 10
16482
2327 [R(int) = 0.0472]
98.3 %
Semi-empirical from equivalents
0.912 and 0.699
Full-matrix least-squares on F2
2327 / 0 / 154
1.054
R1 = 0.0265, wR2 = 0.0662
R1 = 0.0319, wR2 = 0.0691
.356 and -.482 e.A-3
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Table A33. Bond lengths (Å) and angles (°) for bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)benzenesulfide) (22)
Atoms

Bond lengths (Å)

As(1)-S(2)
As(1)-S(1)
As(1)-S(3)
S(1)-C(1)
S(2)-C(2)
S(3)-C(7)
S(4)-C(12)
S(4)-S(4)#1
C(1)-C(6)
C(1)-C(2)
C(2)-C(3)
C(3)-C(4)
C(3)-H(3)
C(4)-C(5)
C(4)-H(4)
C(5)-C(6)
C(5)-H(5)
C(6)-H(6)
C(7)-C(8)
C(7)-C(12)
C(8)-C(9)
C(8)-H(8)
C(9)-C(10)
C(9)-H(9)
C(10)-C(11)
C(10)-H(10)
C(11)-C(12)
C(11)-H(11)

2.2331(6)
2.2465(7)
2.2930(7)
1.765(3)
1.769(3)
1.774(3)
1.791(2)
2.0511(12)
1.396(4)
1.398(4)
1.395(4)
1.386(4)
0.9500
1.384(4)
0.9500
1.384(4)
0.9500
0.9500
1.395(4)
1.403(4)
1.390(4)
0.9500
1.384(4)
0.9500
1.392(4)
0.9500
1.389(4)
0.9500

Atoms

Bond angles (°)

S(2)-As(1)-S(1)
S(2)-As(1)-S(3)
S(1)-As(1)-S(3)
C(1)-S(1)-As(1)
C(2)-S(2)-As(1)
C(7)-S(3)-As(1)

91.86(2)
103.61(2)
102.99(3)
101.30(9)
101.32(9)
103.75(8)
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C(12)-S(4)-S(4)#1
104.03(9)
C(6)-C(1)-C(2)
120.0(2)
C(6)-C(1)-S(1)
118.9(2)
C(2)-C(1)-S(1)
121.0(2)
C(3)-C(2)-C(1)
119.7(2)
C(3)-C(2)-S(2)
119.3(2)
C(1)-C(2)-S(2)
121.0(2)
C(4)-C(3)-C(2)
119.6(3)
C(4)-C(3)-H(3)
120.2
C(2)-C(3)-H(3)
120.2
C(5)-C(4)-C(3)
120.8(3)
C(5)-C(4)-H(4)
119.6
C(3)-C(4)-H(4)
119.6
C(6)-C(5)-C(4)
120.0(2)
C(6)-C(5)-H(5)
120.0
C(4)-C(5)-H(5)
120.0
C(5)-C(6)-C(1)
119.8(2)
C(5)-C(6)-H(6)
120.1
C(1)-C(6)-H(6)
120.1
C(8)-C(7)-C(12)
119.3(2)
C(8)-C(7)-S(3)
120.8(2)
C(12)-C(7)-S(3)
119.89(19)
C(9)-C(8)-C(7)
120.4(2)
C(9)-C(8)-H(8)
119.8
C(7)-C(8)-H(8)
119.8
C(10)-C(9)-C(8)
119.7(2)
C(10)-C(9)-H(9)
120.1
C(8)-C(9)-H(9)
120.1
C(9)-C(10)-C(11)
120.7(3)
C(9)-C(10)-H(10)
119.7
C(11)-C(10)-H(10)
119.7
C(12)-C(11)-C(10)
119.7(2)
C(12)-C(11)-H(11)
120.2
C(10)-C(11)-H(11)
120.2
C(11)-C(12)-C(7)
120.1(2)
C(11)-C(12)-S(4)
123.35(19)
C(7)-C(12)-S(4)
116.57(19)
Symmetry transformations used to generate equivalent atoms: #1 -x+1,y,-z-1/2
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Figure A34. Packing diagram for 2-chloro-benzo-1,3,2-dithiastibole (26). Hydrogen
atoms are omitted for clarity.
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Table A35. Crystal data and structure refinement for 2-chloro-benzo-1,3,2-dithiastibole
(26)
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 27.49
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Extinction coefficient
Largest diff. peak and hole

2-chloro-benzo-1,3,2-dithiastibole
C6H4ClS2Sb
297.41
90.0(2)
0.71073
Orthorhombic
Pbca
8.8985(6)
10.0884(8)
18.7374(15)
90
90
90
1682.1(2)
8
2.349
4.011
1120
0.20 x 0.10 x 0.10
3.16 to 27.49
-11 ≤ h ≤ 8, -13 ≤ k ≤ 12, -24 ≤ l ≤ 23
12586
1928 [R(int) = 0.0419]
99.9 %
Semi-empirical from equivalents
0.6898 and 0.5592
Full-matrix least-squares on F2
1928 / 0 / 92
1.112
R1 = 0.0284, wR2 = 0.0620
R1 = 0.0429, wR2 = 0.0685
0.00200(16)
1.252 and -.870 e.A-3
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Table A36. Bond lengths (Å) and angles (°) for 2-chloro-benzo-1,3,2-dithiastibole (26)
Atoms

Bond lengths (Å)

Sb(1)-S(2)
Sb(1)-S(1)
Sb(1)-Cl(1)
S(1)-C(1)
S(2)-C(6)
C(1)-C(6)
C(1)-C(2)
C(2)-C(3)
C(2)-H(2)
C(3)-C(4)
C(3)-H(3)
C(4)-C(5)
C(4)-H(4)
C(5)-C(6)
C(5)-H(5)

2.4037(10)
2.4118(9)
2.4563(9)
1.774(4)
1.768(4)
1.389(5)
1.401(5)
1.392(6)
0.9500
1.387(6)
0.9500
1.384(6)
0.9500
1.400(5)
0.9500

Atoms

Bond angles (°)

S(2)-Sb(1)-S(1)
S(2)-Sb(1)-Cl(1)
S(1)-Sb(1)-Cl(1)
C(1)-S(1)-Sb(1)
C(6)-S(2)-Sb(1)
C(6)-C(1)-C(2)
C(6)-C(1)-S(1)
C(2)-C(1)-S(1)
C(3)-C(2)-C(1)
C(3)-C(2)-H(2)
C(1)-C(2)-H(2)
C(4)-C(3)-C(2)
C(4)-C(3)-H(3)
C(2)-C(3)-H(3)
C(5)-C(4)-C(3)
C(5)-C(4)-H(4)
C(3)-C(4)-H(4)
C(4)-C(5)-C(6)
C(4)-C(5)-H(5)
C(6)-C(5)-H(5)
C(1)-C(6)-C(5)

88.39(3)
93.41(3)
93.84(3)
100.50(13)
100.69(13)
119.7(4)
123.7(3)
116.6(3)
120.1(4)
120.0
120.0
120.3(4)
119.8
119.8
119.5(4)
120.2
120.2
120.9(4)
119.5
119.5
119.5(3)
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C(1)-C(6)-S(2)
C(5)-C(6)-S(2)

123.8(3)
116.7(3)
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Figure A37. Molecular structure for 1,2-benzenedithiol.
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Figure A38. Packing diagram for 1,2-benzenedithiol. Hydrogen atoms are omitted for
clarity.
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Table A39. Crystal data and structure refinement for 1,2-benzenedithiol
Compound
Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Volume (Å3)
Z
Calculated density (Mg/m3)
Absorption coefficient (mm-1)
F(000)
Crystal size (mm)
Theta range for data collection (°)
Limiting indices
Reflections collected
Unique reflections
Completeness to theta = 27.46
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2σ(I)]
R indices (all data)
Largest diff. peak and hole

1,2-benzendithiol
C6H6S2
142.23
90.0(2)
0.71073
Triclinic
P-1
7.6005(1)
10.0250(2)
10.0395(2)
95.5119(8)
111.1513(9)
108.9276(9)
654.87(2)
4
1.443
0.694
296
0.20 x 0.10 x 0.05
2.21 to 27.46
-9<=h<=9, -12<=k<=13, -12<=l<=12
5777
2977 [R(int) = 0.0254]
99.7 %
Semi-empirical from equivalents
0.9661 and 0.8736
Full-matrix least-squares on F2
2977 / 0 / 161
1.084
R1 = 0.0313, wR2 = 0.0749
R1 = 0.0450, wR2 = 0.0806
.346 and -.296 e.A-3
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Table A40. Bond lengths (Å) and angles (°) for 1,2-benzenedithiol
Atoms

Bond lengths (Å)

S(1A)-C(1A)
S(1A)-H(1SA)
S(2A)-C(2A)
S(2A)-H(2SA)
C(1A)-C(6A)
C(1A)-C(2A)
C(2A)-C(3A)
C(3A)-C(4A)
C(3A)-H(3A)
C(4A)-C(5A)
C(4A)-H(4A)
C(5A)-C(6A)
C(5A)-H(5A)
C(6A)-H(6A)
S(1B)-C(1B)
S(1B)-H(1SB)
S(2B)-C(2B)
S(2B)-H(2SB)
C(1B)-C(3B)
C(1B)-C(2B)
C(2B)-C(6B)
C(3B)-C(4B)
C(3B)-H(3B)
C(4B)-C(5B)
C(4B)-H(4B)
C(5B)-C(6B)
C(5B)-H(5B)
C(6B)-H(6B)

1.7704(17)
1.23(2)
1.7697(17)
1.23(2)
1.393(2)
1.399(2)
1.397(2)
1.389(3)
0.9500
1.384(3)
0.9500
1.392(3)
0.9500
0.9500
1.7738(17)
1.25(2)
1.7678(17)
1.25(2)
1.394(2)
1.399(2)
1.397(2)
1.382(2)
0.9500
1.391(2)
0.9500
1.383(2)
0.9500
0.9500

Atoms

Bond angles (°)

C(1A)-S(1A)-H(1SA)
C(2A)-S(2A)-H(2SA)
C(6A)-C(1A)-C(2A)
C(6A)-C(1A)-S(1A)
C(2A)-C(1A)-S(1A)
C(3A)-C(2A)-C(1A)
C(3A)-C(2A)-S(2A)
C(1A)-C(2A)-S(2A)
C(4A)-C(3A)-C(2A)

96.6(11)
96.0(10)
119.94(15)
122.03(14)
118.03(13)
119.74(16)
122.21(14)
118.05(12)
119.95(17)
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C(4A)-C(3A)-H(3A)
C(2A)-C(3A)-H(3A)
C(5A)-C(4A)-C(3A)
C(5A)-C(4A)-H(4A)
C(3A)-C(4A)-H(4A)
C(4A)-C(5A)-C(6A)
C(4A)-C(5A)-H(5A)
C(6A)-C(5A)-H(5A)
C(5A)-C(6A)-C(1A)
C(5A)-C(6A)-H(6A)
C(1A)-C(6A)-H(6A)
C(1B)-S(1B)-H(1SB)
C(2B)-S(2B)-H(2SB)
C(3B)-C(1B)-C(2B)
C(3B)-C(1B)-S(1B)
C(2B)-C(1B)-S(1B)
C(6B)-C(2B)-C(1B)
C(6B)-C(2B)-S(2B)
C(1B)-C(2B)-S(2B)
C(4B)-C(3B)-C(1B)
C(4B)-C(3B)-H(3B)
C(1B)-C(3B)-H(3B)
C(3B)-C(4B)-C(5B)
C(3B)-C(4B)-H(4B)
C(5B)-C(4B)-H(4B)
C(6B)-C(5B)-C(4B)
C(6B)-C(5B)-H(5B)
C(4B)-C(5B)-H(5B)
C(5B)-C(6B)-C(2B)
C(5B)-C(6B)-H(6B)
C(2B)-C(6B)-H(6B)

120.0
120.0
120.13(17)
119.9
119.9
120.51(17)
119.7
119.7
119.72(18)
120.1
120.1
96.6(11)
97.2(9)
119.84(15)
122.14(13)
118.02(13)
119.25(16)
122.68(13)
118.06(12)
120.38(17)
119.8
119.8
119.99(17)
120.0
120.0
120.10(16)
120.0
120.0
120.44(16)
119.8
119.8
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Appendix B: List of Symbols and Abbreviations
General:
Å angstrom, 10-10 m
ATP adenosine triphosphate
DMA(III) dimethylarsinous acid
DMA(V) dimethylarsinic acid
EI Electron Impact
g grams
GOF goodness of fit
GSH glutathione, GS
Hz hertz, s-1
K Kelvin
M molar
M+ molecular ion
Me methyl, CH3
mg milligrams
min minutes
mL milliliters
mmol millimoles
MMA(III) monomethylarsonous acid
MMA(V) monomethylarsonic acid
mp melting point
Ph phenyl
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ppm parts per million
R R-factor
Rw weighted R-factor
s seconds
t time
T temperature
THF tetrahydrofuran
For nuclear magnetic resonance spectra:
δ chemical shift (in parts per million)
d doublet
m multiplet
NOE nuclear Overhauser effect
NMR nuclear magnetic resonance
s singlet
For infrared spectra:
br broad
cm-1 wavenumbers
FT-IR Fourier Transform Infrared Spectra
m medium
s strong
ν vibrational frequency (cm-1)
w weak
Copyright © Taimur Shaikh 2007
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